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Summary Guide for Investigators
Who must follow the UIUC policy and procedures?
Any individual who is responsible for a research activity involving human
subjects conducted at or sponsored by the University of Illinois.
Who may conduct research involving human subjects?
Any research involving human subjects must have associated with it a
Responsible Project Investigator who is a qualified faculty member at
or above the level of instructor, or a qualified staff member, and who will
monitor the conduct of the research.
To what activities do the UIUC policy and procedures apply?
To any research activity which involves human subjects, whether such
research is undertaken on a large or small scale, whether it is preliminary
or fully designed, whether it is student or faculty research, whether it
is externally funded or not, and whether it involves minimal risk or more
than minimal risk. (See Part II, Section A, page 5.)
What is meant by the terms human subject, research, minimal risk,
informed consent?
See Part II, Sections G and D, pages 8-20.
What are the requirements for informed consent?
The voluntary informed consent of subjects is a basic ethical principle
essential to the conduct of all research with humans whether or not the
research is governed by federal regulations and whether or not the re-
search is subject to prior review.
The requirements regarding methods used to obtain consent and docu-
mentation of the consent process vary according to the nature of the
project and its sponsorship. (See Part II, Section D, pages 12-20.)
What kinds of research require review?
All research involving human subjects must be submitted for review
unless the only involvement of human subjects will comply fully with the
criteria for one or more of the exemption categories set forth in Part III,
Section A, pages 28-34.
What is the purpose of the review?
To obtain an independent determination of whether the research meets
the criteria for approval set by UIUC and certain sponsoring agencies.
(See Tables 6A and 6B, pages 41-44.)
m
When must a nonexempt research activity involving human subjects be
reviewed?
Prior to the initiation of activity (unless the research is necessary to
eliminate apparent immediate hazards to the human subject), prior to
the implementation of changes in previously approved procedures in-
volving human subjects, and at least annually during the lifetime of the
project. If the project is being proposed for external funding, review
should take place prior to or shortly after submission of a proposal to the
sponsor. (See Part III, Section C, pages 38-39.)
Who will perform the review?
The locus of the review depends on the nature of the activity and the
source of funding. (See Table 5, Part III, page 36.)
What is the review process?
See Figure 1, Part III, page 37.
What must be submitted for review?
Form IRB-1 (or a department's substitute therefor) providing sufficient
information for the Institutional Review Board (IRB) or IRB-approved
departmental review body to make a fair and reasonable judgment as
to the project's compliance with all requirements. (See Part III, Section
F, pages 40, 44, and 45, for greater detail.)
How will the principal investigator find out the result of the review?
Via written notification from the review body.
How can an investigator obtain information or advice regarding use of
human subjects?
Contact the Executive Secretary of the Institutional Review Board
(333-2670) who will either provide the information or arrange for con-
sultation with one or more members of the IRB.
Are there special requirements if certain kinds of subjects, such as chil-
dren, pregnant women, or prisoners are included in the research?
Yes. See Appendix IV, pages 67-74.
Are there special requirements if access to subjects is gained through
cooperating institutions not under UIUC control?
Yes. See Part III, Section F2tf and k, pages 44 and 45.
Are there special requirements if plans for use of human subjects are
indefinite or arise during the course of a project in which no use of
subjects was planned?
Yes. See Part III, Section C, pages 38-39.
IV
How should emergencies involving human subjects be handled?
Contact McKinley Health Center (333-2700). State the location and the
nature of the emergency. Inform McKinley personnel of the relationship
of the emergency to the research activity; give the principal investigator's
name and telephone number.
Promptly report any such event to the Departmental Executive Officer
and the Institutional Review Board (333-2670).
What are the subjects' responsibilities and privileges?
Subjects are free to ask questions and withdraw from participation at any
time. They may have access to a copy of the UIUC policy and procedures.
Subjects may take unresolved complaints or concerns to the Depart-
mental Executive Officer and, if the matter remains unresolved, to the
Executive Secretary of the Institutional Review Board.
Subjects are expected to notify the investigator promptly if adverse
effects of participation are experienced.
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Part I: Ethical and Professional Standards
for Use of Human Subjects
in Research
The use of human subjects in research can be extremely important to
the development of new knowledge in many areas. Ultimately, the only
sure means for learning specifically about man is through studying man
himself. Responsible investigation involving human beings as subjects,
however, demands that careful attention be given to questions of ethics
and human dignity. During the War Crimes Trials following World
War II, the Nuremberg Code1 was drafted as a set of standards for judg-
ing physicians and scientists who had conducted biomedical experiments
on concentration camp prisoners. This code has been widely adopted
by investigators conducting studies on human beings and has served as
the prototype of many later codes intended to ensure that research in-
volving human subjects would be carried out in an ethical manner.
Since 1947, various codes for the proper and responsible conduct of re-
search involving human subjects have been developed by professional asso-
ciations to guide investigators working in the various disciplines involved.
Over the years, experience has shown that while these codes have been
helpful, they are frequently difficult to interpret or to apply, particularly
in nonmedical research projects which involve human subjects. As part
of its work, the National Commission for the Protection of Human Sub-
jects in Biomedical and Behavioral Research developed broader ethical
principles to provide a basis on which specific rules could be formulated,
criticized and interpreted. These principles are discussed in The Belmont
Report*
1 Trials of War Criminals Before the Nuremberg Military Tribunals. Superintendent
of Documents, U.S. Government Printing Office, Washington, D.C. (1947).
1 The Belmont Report: Ethical Principles and Guidelines for the Protection of
Human Subjects of Research. The National Commission for the Protection of
Human Subjects of Biomedical and Behavioral Research, DHEW Publication No.
(OS) 78-0012 (1978).
The Belmont Principles and the Nuremberg Code are stated below.
Appendix I of this document gives a listing of the various ethical codes
developed by professional associations and the addresses from which
copies may be obtained. The Office of the Executive Secretary of the
Institutional Review Board, 125 Coble Hall, and the University Library
have copies of these ethical codes available for review.
A. The Belmont Principles
Three basic principles, among those generally accepted in our cultural
tradition, are particularly relevant to the ethics of research involving
human subjects: respect for persons, beneficence, and justice.
1. Respect for Persons
Respect for persons incorporates at least two basic ethical tenets:
first, that individuals should be treated as autonomous agents and
second, that persons with diminished autonomy are entitled to pro-
tection. The principle of respect for persons thus divides into two
separate moral requirements: the requirement to acknowledge auton-
omy and the requirement to protect those with diminished autonomy.
To respect autonomy is to give weight to autonomous persons' con-
sidered opinions and choices while refraining from obstructing their
actions unless they are clearly detrimental to others. Respect for the
immature and the incapacitated may require protecting them as
they mature or while they are incapacitated.
In most cases of research involving human subjects, respect for per-
sons demands that subjects enter the research voluntarily and on the
basis of adequate information about the research situation and pos-
sible consequences.
2. Beneficence
Persons are treated in an ethical manner not only by respecting their
decisions and protecting them from harm, but also by making efforts
to secure their well-being. Such treatment falls under the principle of
beneficence. Two general rules have been formulated as complemen-
tary expressions of beneficent actions in this sense: (1) do not harm
and (2) maximize possible benefits and minimize possible harms.
Learning what will, in fact, benefit may require exposing persons to
risk. The problem posed by these imperatives is to decide when it is
justifiable to seek certain benefits, despite the risks involved, and when
the possible benefits should be foregone because of the risks.
The obligations of beneficence affect both individual investigators
and society at large, because they extend both to particular research
projects and to the entire enterprise of research. In the case of par-
ticular projects, investigators and members of their institutions are
obliged to give forethought to the maximization of benefits and the
reduction of risks that might occur from the research investigation. In
the case of scientific research in general, members of the larger society
are obliged to recognize the longer term benefits and risks that may
result from the improvement of knowledge and from the development
of novel medical, psychotherapeutic, and social procedures.
3. Justice
Who ought to receive the benefits of research and bear its burdens?
This is a question of justice— in the sense of "fairness in distribution"
or "what is deserved." An injustice occurs when some benefit to which
a person is entitled is denied without good reason or when some bur-
den is imposed unduly. The selection of research subjects needs to be
scrutinized in order to determine whether some groups (e.g., welfare
patients, particular racial and ethnic minorities, or persons confined
to institutions) are being systematically selected simply because of
their easy availability, their compromised position, or their manipula-
bility, rather than for reasons directly related to the problem being
studied. Especially when research supported by public funds leads to
the development of therapeutic devices and procedures, justice de-
mands that such research should not unduly involve persons from
groups unlikely to be among the beneficiaries of subsequent applica-
tions of the research.
B. The Nuremberg Code
1. The voluntary consent of the human subject is absolutely essential.
2. The experiment should be such as to yield fruitful results for the
good of society, unprocurable by other methods or means of study,
and not random and unnecessary in nature.
3. The experiment should be so designed and based on the results of
animal experimentation and a knowledge of the natural history of
disease or other problem under study that the anticipated results
will justify the performance of the experiment.
4. The experiment should be so conducted as to avoid all unnecessary
physical and mental suffering and injury.
5. No experiment should be conducted where there is an a priori reason
to believe that death or disabling injury will occur— except perhaps
in those experiments where experimental physicians also serve as
subjects.
6. The degree of risk to be taken should never exceed that determined
by the humanitarian importance of the problem to be solved by the
experiment.
7. Proper preparations should be made and adequate facilities provided
to protect the experimental subject against even remote possibilities
of injury, disability, or death.
8. The experiment should be conducted only by scientifically qualified
persons. The highest degree of skill and care should be required
through all stages of the experiment of those who conduct or engage
in the experiment.
9. During the course of the experiment, the human subject should be
at liberty to bring the experiment to an end if he has reached the
physical or mental state where continuation of the experiment seems
to him to be impossible.
1 0. During the course of the experiment, the scientist in charge must be
prepared to terminate the experiment at any stage if he has probable
cause to believe, in the exercise of good faith, superior skill, and care-
ful judgment required of him, that a continuation of the experiment
is likely to result in injury, disability, or death to the experimental
subject.
Part II: UIUC Policy for Use of Human
Subjects in Research
A. Applicability
This policy is applicable to any research activity conducted at or spon-
sored by the University of Illinois at Urbana-Champaign which involves
human subjects, i.e., living individuals about whom an investigator (pro-
fessional or student) conducting research obtains (1) data through inter-
vention or interaction with the individual or (2) identifiable private
information. The policy is therefore applicable to research involving
human beings whose physical, emotional, or behavioral condition, re-
sponses, tissues, or fluids are investigated for any purpose other than for
the sole purpose of benefiting the subject as an individual. It is applicable
to the use of interviews, tests, observations, and inquiries designed to elicit
or obtain nonpublic information about individuals or groups.
The policy is applicable whether the research is undertaken on a large
or small scale. Pilot projects, student dissertation projects, independent
study projects, and course projects must follow this policy if they involve
human subjects in research.
B. Statement of Policy
The University of Illinois at Urbana-Champaign affirms the need for
academic freedom in the conduct of research and the value of well-
designed, responsible activities which involve human subjects. At the
same time, it recognizes its basic responsibility to assure the protection of
any human subjects so involved. To this end, it has adopted the following
statement of policy:
1 . Investigations conducted at or sponsored by the University of Illinois
at Urbana-Champaign must:
a. adhere to the Belmont Principles, and
b. comply with the Nuremberg Code or one of the ethical codes de-
veloped by the various professional associations, and
c. adhere to the policies and procedures set forth in this document.
2. Participation of human beings as subjects in research governed by this
policy must be voluntary, i.e., it must occur as the result of free choice,
without compulsion or obligation.
Both the rights of such individuals to be protected against injury
or invasions of their privacy and their interests as members of a free
society in preserving their dignity are recognized as major concerns
and must be protected. Therefore, research involving human subjects
should be undertaken only with the voluntary consent of the subject
or, if the subject lacks the capacity to consent, with the consent of
his or her authorized representative.
Where minors, mentally retarded, or mentally disabled persons, in-
dividuals with limited civil freedom, pregnant women, fetuses, or
children are subjects in research, special care must be taken to assure
that consent for participation is obtained in accordance with appli-
cable statutes and regulations. The consent of authorized representa-
tives is usually required for subjects who have diminished capacity
to consent. The assent of the subjects themselves is usually required as
well as the consent of their representatives.
3. Adequate standards for informed consent must be satisfied.
In addition to voluntariness as described above, disclosure and
comprehension are essential elements of the consent process.
Disclosure generally includes: the research procedures; their pur-
poses, risks, and anticipated benefits; alternative procedures where
therapy is involved; and a statement offering the subject the oppor-
tunity to ask questions and to withdraw at any time from the research.
The extent and nature of information should be such that persons,
knowing that the procedures are neither necessary for their care nor
perhaps fully understood, can decide whether they wish to participate
in the furthering of knowledge. Even when some direct benefit to
them is anticipated, subjects should understand clearly the range of
risk and the voluntary nature of participation.
In some research, fully informing the subject would invalidate the
research. In such cases, it may be necessary to withhold information
from the subject. However, information should not be withheld if
withholding it would affect a reasonable person's decision to partici-
pate or damage his or her subsequent self-esteem. Information about
risks should never be withheld for the purpose of eliciting the coop-
eration of subjects, and truthful answers should always be given to
direct questions about the research.
Incomplete disclosure is only justified if it is clear that
:
a. incomplete disclosure is truly necessary to accomplish the goals of
the research,
b. there are no undisclosed risks to subjects that are more than min-
imal, and
c. where appropriate, there is an adequate plan for debriefing subjects
and disseminating research results to them.
Care should be taken to distinguish cases in which disclosure would
destroy or invalidate the research from cases in which disclosure
would simply inconvenience the investigator.
Comprehension is the third essential element in informed consent.
The manner and context in which information is conveyed is as im-
portant as the information itself. Consideration must be given to the
subject's ability to understand the language and terminology used as
well as the subject's physical and mental state. Investigators are re-
sponsible for ascertaining that the subject has comprehended the in-
formation.
Additional details regarding the consent process and certain re-
quirements for documentation of consent are given in Section Dl,
UIUC standards for consent, pages 12-20.
4. Adequate provision must be made to protect the privacy of subjects
and to maintain the confidentiality of identifiable information.
Confidentiality provisions must meet reasonable standards for pro-
tection of privacy and comply with applicable laws. Identifiable infor-
mation must not be disclosed outside the research group unless the
subjects expressly agree otherwise.
5. The selection of subjects must be carefully considered.
The principle of justice gives rise to moral requirements that there
be fair procedures and outcomes in the selection of research subjects.
For example, individual justice dictates that subjects should not be
selected for potentially beneficial research on the basis of favoritism.
Nor should risky research be restricted to subjects who are powerless.
Social justice requires recognition of differences among groups in the
ability to bear burdens; gives an order of preference in the selection
of types of subjects (for example, adults before children) ; and dictates
that some types of persons (for example, institutionalized mentally
infirm or prisoners) may be involved as research subjects only on cer-
tain conditions.
Certain groups, such as racial minorities, the economically disad-
vantaged, the very sick, and the institutionalized, may continually be
valuable as research subjects owing to their ready availability in
settings where research is conducted. Given their dependent status
and their frequently compromised capacity for free consent, they
should be protected against the danger of being involved in research
solely for administrative convenience or because they are easy to
manipulate as a result of their illness or socioeconomic condition.
6. The methods used for approaching subjects and securing their par-
ticipation should be designed carefully to protect the privacy of the
subjects and should be reasonable in terms of their condition or cir-
cumstances.
No coercion, explicit or implicit, should be used to obtain or main-
tain cooperation. Where the professional-client or faculty-student re-
lationship is converted into an investigator-subject relationship, special
care must be taken to assure that the subject feels completely free to
decline to participate. Where access to subjects is gained through
cooperating institutions or individuals, care should be taken not to
abridge prior commitments made to the subjects about the confiden-
tiality or other terms of the primary relationship.
7. Any payment made to subjects should not be large enough to consti-
tute excessive inducement for participation of the subjects.
8. Projects involving human subjects should be carefully designed to
minimize risk to the subjects.
As far as possible, any risk should be anticipated in advance. Proper
precaution should be taken and plans made to deal with emergencies
that may develop in the course of even seemingly routine activities.
9. Except for certain kinds of research, described in Section A of Part
III, all research involving human subjects conducted at or sponsored
by the University of Illinois at Urbana-Champaign must be submitted
for prior review and timely periodic review after approval, in accor-
dance with the policies and procedures of the Institutional Review
Board. Furthermore, changes in approved research may not be initi-
ated without prior review.
C. Definition of Terms
1. Research
Human beings may be studied in many ways and under a vast variety
of circumstances and conditions. For these reasons, the word research
is elusive and difficult to define with precision. On the one hand,
research may be used to describe something as innocuous as a new
approach to teaching or the questions in a public opinion survey. On
the other hand, research may refer to procedures in which the subject
may be exposed to the gravest mortal risks, such as the astronaut who
prepares to be launched into space to orbit the earth or journey to
the moon.
As used in this document, the word research is defined as a trial or
special observation, usually made under conditions determined by the
investigator, which aims to test a hypothesis, to discover some un-
known principle or effect, or to re-examine some known or suggested
truth. The term research is intended to apply to systematic studies in
which any substance or stimulus is administered to a subject by any
route. It is intended to apply to studies which involve changes in
physical or psychological state or environment or major changes in
diet and to the pertinent methods for studying alterations in body
functions and behavior under such conditions. It is intended to apply
to the use of interviews, tests, observations, and inquiries designed to
elicit or obtain nonpublic information about individuals or groups.
Activities which meet this definition constitute research whether or
not they are supported or funded under a program which is considered
research for other purposes. For example, some demonstration and
service programs may include research activities.
The term research is not intended to apply to routine course devel-
opment, including evaluation of the effectiveness of such development,
of courses sponsored by the University of Illinois.
2. Human Subject
The term human subject means a living individual about whom an
investigator (professional or student) conducting research obtains
• data through intervention or interaction with the individual, or
• identifiable private information.
Intervention includes both physical procedures by which data are
gathered (for example, venipuncture) and manipulations of the sub-
ject or the subjects' environment that are performed for research pur-
poses. Interaction includes communication or interpersonal contact
between investigator and subject. Private information includes infor-
mation about behavior that occurs in contexts in which an individual
can reasonably expect that no observation or recording is taking place
and information which has been provided for specific purposes by an
individual and which the individual can reasonably expect will not
be made public (for example, a medical record). Information is
individually identifiable if the identity of the subject is, or may be,
readily ascertained by the investigator or associated with the informa-
tion.
The definition of subject excludes all accepted and established ser-
vice relationships, such as the normal relationship of patients to physi-
cians, students to professors, and other clients to professionals in which
the patient, student, or client is receiving aid or services consistent with
accepted and established practice, and intended only to meet his or her
own personal needs. The professional-client relationship has the wel-
fare of the client as the primary objective, whereas the investigator-
subject relationship has the discovery of new knowledge as its primary
objective. This difference may not be fully understood by the subject
who is also a client, and can result in the investigator's gaining consent
without free decision— in part due to a trust based on a presumed
role which the investigator is not necessarily fulfilling at that time.
The normal employer-employee relationship, in which legitimate
services are rendered for salary, wages, or remuneration in keeping
with customary written or verbal contracts, is also excluded from the
definition of subject. Payment of subjects does not alter their status
as subjects.
If doubt exists as to whether the procedures to be employed are
within accepted and established practice or whether the purpose is
only for the personal needs of the client, the activity should be con-
sidered to involve subjects whose rights and welfare are to be protected
in accord with this policy statement. Similarly, if doubt exists as to
whether the procedures are within the normal limits of the employee's
work scope, employees should be considered to be participating as
human subjects, and their rights and welfare must be protected.
a. Types of Subjects
There are several types of human subjects. For example, the sub-
ject may be an adult, a minor, a student, a hospitalized patient, a
client, a resident of an institution for the mentally ill or retarded,
a prison inmate, etc. Informants, and donors of organs, tissues, body
fluids, and of services are also considered to be subjects. (Such
donors are subjects only if what they provide is used for research
purposes.)
Of particular concern are the following types of subjects:
i. Children, including the newborn and minors, because of their
vulnerability, diminished autonomy, and incomplete understand-
ing;
ii. Subjects with limited civil freedom, such as prisoners, residents
or clients of institutions for the mentally ill and mentally re-
tarded, and persons subject to military discipline ; and
Hi. Pregnant women and the viable fetus, both in utero and ex
utero. (The unborn should be considered subjects to the extent
that they have rights that can be exercised by their next of kin
or legally authorized representative.)
3. Minimal Risk
Minimal risk means that the risks of harm anticipated in the proposed
research are not greater, considering probability and magnitude, than
those ordinarily encountered in daily life or during the performance
of routine physical or psychological examinations or tests.
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Certain risks are inherent in life itself, at the time and in the places
where life runs its course. Risks of daily life include the ordinary risks
of public or private living; those risks associated with admission to a
school or hospital; and the risk inherent in professional practice, as
long as these do not exceed the bounds of established and accepted
procedures, including innovative practices applied in the interest of
the individual patient, student, or client.
The fact that some types of research do not involve risks beyond
those experienced in daily life situations does not mean that the in-
vestigator is any less responsible for his or her subjects.
Section D3c provides the special safeguards required for activities
involving minimal risk and activities involving greater than minimal
risk. It also provides examples of types of research which fall into each
of these two categories.
4. Responsible Project Investigator
Responsible project investigator means a qualified faculty member at
or above the level of instructor or a qualified staff member who will
monitor the conduct of research involving human subjects.
5. Children
Children means persons who have not attained the legal age for con-
sent to treatments or procedures involved in research, under the ap-
plicable law of the jurisdiction in which the research will be con-
ducted. (In Illinois this age is eighteen years.)
6. Legally Authorized Representative, Parent, Guardian
Legally authorized representative means an individual or other body
authorized under applicable law to consent on behalf of a prospective
subject to the subject's participation in the procedure (s) involved in
the research.
Parent means a child's biological or adoptive parent.
Guardian means an individual who is authorized under applicable
state or local laws to consent on behalf of a child to general medical
care.
7. Advocate
Advocate means an individual who has the background and ex-
perience to act in, and agrees to act in, the best interests of the child
for the duration of the child's participation in the research and who
is not associated in any way (except in the role as advocate or member
of the IRB) with the research, the investigator (s), or the guardian
organization.
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D. UIUC Standards
1. Informed Consent
The ethical and professional codes governing the use of human sub-
jects in research all require that the participation of the subject must
be voluntary, i.e., the subject gives his or her informed consent, or his or
her authorized representative consents if the subject lacks the capacity
to consent.
The principle of voluntary participation of subjects applies whether
or not the research is governed by federal regulations and whether
or not the research is subject to prior review.
The methods used to obtain consent may vary. They should be
designed to fit the nature of the research, the nature and magnitude of
the risks involved, the research setting, the nature of the subjects who
will participate, and the requirements of applicable policies, laws, and
regulations.
a. Core Elements of Consent
The core requirements for informed consent are:
• disclosure of the nature and general purpose of the research pro-
cedures and identification of any procedures which are experi-
mental;
• disclosure of any risks and the anticipated benefits of the re-
search, either to the subject or to society;
• where therapy is involved, a description of alternative procedures
or courses of treatment, if any, that might be advantageous to
the subject; and
• provision for assuring that the subjects understand they may ask
questions and/or withdraw at any time from the research.
Please note that additional elements of informed consent are re-
quired for work governed by the Department of Health and Human
Services (HHS) (i.e., all work supported by HHS and other agencies
which have adopted the HHS regulations) . The specific elements
required by HHS regulations are given in Table 1, pages 16-19.
The Institutional Review Board may approve a consent process
which does not include, or which alters, any or all of the four elements
of consent set forth above if it believes that the modifications are
necessary, if they do not adversely affect the rights and welfare of the
subjects, and if they are permitted by applicable laws and regulations.
Table 1 includes the special criteria the Institutional Review Board
must follow to modify some or all of the elements of consent set forth
in the HHS requirements.
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b. Additional Consent Requirements
Five additional requirements regarding consent must be met:
• The consent may not include any exculpatory language through
which the subject is made to waive, or appear to waive, any of
his or her legal rights, including any release of the institution or its
agents from liability or negligence.
• Applicable federal, state, or local laws which require additional
information to be disclosed in order for informed consent to be
legally effective must be complied with.
• The consent requirements described herein place no limits on
the authority of a physician to provide emergency medical care,
to the extent the physician is permitted to do so under applicable
federal, state, or local law.
• When children are involved as subjects in research and are
capable of assent, normally their assent to participate must be
solicited in addition to the permission of their parents.
• Where participation as human subjects of students enrolled in
a course of instruction at UIUG forms an integral part of the
conduct of the course, the official University bulletins and time-
tables shall state that fact in the description of the course. A
statement such as the following shall be included in the course
description: "Includes limited voluntary participation as a sub-
ject in research activities."
This statement will serve to alert registrants of this character-
istic of the course, but would not suffice as the only means of
assuring that the subjects' participation in a specific research
activity is voluntary. Care must be exercised to assure the absence
of coercion, either real or perceived, in utilizing students as sub-
jects.
c. Consent Process
An investigator shall seek consent only under circumstances that
provide the prospective subject or the subject's representative suffi-
cient opportunity to consider whether or not to participate and that
minimize the possibility of coercion or undue influence. The infor-
mation that is given to the subject or the representative shall be
in language understandable to the subject or the representative.
Investigators are responsible for ascertaining that the subject or
subject's representative has comprehended the information.
Occasionally, fully informed consent may itself have an injurious
effect on the subject, or it may invalidate the research. Incomplete
disclosure is only justified if it is clear that:
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• incomplete disclosure is truly necessary to accomplish the goals
of research or to protect the subjects; and
• there are no undisclosed risks to subjects that are more than
minimal; and
• where appropriate, there is an adequate plan for debriefing sub-
jects and for dissemination of research results to them.
Information shall not be withheld if withholding it would influ-
ence a reasonable person's decision to participate or damage his or
her subsequent self-esteem. Information about risks shall never be
withheld for the purpose of eliciting the cooperation of subjects,
and truthful answers should always be given to direct questions
about the research. Care shall be taken to distinguish cases in which
disclosure would destroy or invalidate the research from cases in
which disclosure would simply inconvenience the investigator.
In research which requires prior review, the justification for in-
complete disclosure must be explicitly stated in the materials sub-
mitted for review.
The methods used to obtain consent may vary. They should be
designed to fit the nature of research, the nature and magnitude of
the risks involved, the research setting, and the nature of the sub-
jects who will participate.
i. Consent Methods for Minimal Risk Research
When the research does not place the subjects at more than
minimal risky there is no single method required to assure that
the subject consents to participation. For example, consent may
be secured by a written document; it may be obtained orally; it
may be implicit in voluntary participation in a well-advertised
activity; or, in the case of research in commonly accepted educa-
tional settings and involving normal educational practices the
consent of the appropriate educational officials may serve as a
substitute for the individual subject's consent.
If, however, a written consent form is used, it should include
at least the core requirements for informed consent given above
and should also include the telephone number of an individual
who will be available to answer inquiries from subjects. When
a written consent form is used, a copy should be given to the
subject. If the basic elements of consent are presented orally
and only the subject's formal consent is obtained in writing, the
subject should be given a copy of a written summary of the oral
explanation.
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For those research projects which require prior review in
accordance with the IRB policies and procedures, the materials
submitted for review must include a copy of the written consent
form and summary of oral explanation, if any. (Examples of
consent forms are provided in Appendix II.)
«. Consent Methods for Research Involving More Than
Minimal Risk
When the research places the subjects at more than minimal
risk, the investigator is obligated to obtain legally effective in-
formed consent, and a written consent document is usually
preferred. The consent document must be approved by the
Institutional Review Board. It must be signed by the subject or
the subject's legally authorized representative. A copy must be
given to the person signing the form. The subject or the sub-
ject's legally authorized representative must be given an op-
portunity to read the form before it is signed, even if the consent
form is read to the subject.
The written informed consent document may either be a
long-form document incorporating all the basic elements of
informed consent or a short-form document which makes refer-
ence to an oral presentation of the basic elements of informed
consent. If the short form is used, the Institutional Review Board
must approve a written summary of what is to be said to the
subject or the subject's representative. Further, there must be a
witness to the oral presentation when the short form is used.
Whereas the subject or his or her representative only needs to sign
the short form itself, the witness and the person actually obtain-
ing consent must sign both the short form and a copy of the
summary. A copy of the summary must be given to the subject
or his or her representative in addition to a copy of the short con-
sent form. (Examples of consent forms are provided in Appendix
II.)
The Institutional Review Board may waive the requirement
for the investigator to obtain a signed consent form for some
or all subjects if it finds that the only record linking the subject
and the research would be the consent document and the prin-
ciple risk would be potential harm resulting from a breach of
confidentiality.
d. Documentation of Consent
For research which involves only minimal risk, the investigator
must keep a description of the consent process used. If a written
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consent document is used, the investigator must keep a copy of a
sample of the consent form. The investigator is advised to retain
copies of the signed consent documents themselves for three years
from the date the consent was obtained. (Examples of consent
forms are provided in Appendix II.)
If the research involves more than minimal risk, the investigator
must retain copies of a sample of the written consent form, copies
of the signed consent documents, a copy of the written summary
of an oral explanation, if any, signed by the person obtaining con-
sent and the witness to the oral explanation. These consent docu-
ments must be retained for a period of three years after the consent
was obtained, unless applicable law or supporting agency require-
ments demand a longer retention of such records.
If the Institutional Review Board permits use of a method
other than written informed consent for research involving more
than minimal risk, the investigator and the Institutional Review
Board should retain a copy of the description of the method used
and the justification for waiving the requirement for written in-
formed consent.
Note that work governed by the HHS regulations must comply
with the documentation requirements set forth in Table 2, page 20.
(Text continues on page 21.)
TABLE 1: HHS REQUIREMENTS* FOR INFORMED CONSENT
A. Basic Elements of Informed Consent
(a) Basic elements of informed consent. Except as provided in paragraph (c) of
this section, in seeking informed consent the following information shall be
provided to each subject:
( 1 ) A statement that the study involves research, an explanation of the pur-
poses of the research and the expected duration of the subject's par-
ticipation, a description of the procedures to be followed, and identifi-
cation of any procedures which are experimental;
(2) A description of any reasonably foreseeable risks or discomforts to the
subject;
(3) A description of any benefits to the subject or to others which may
reasonably be expected from the research;
(4) A disclosure of appropriate alternative procedures or courses of treat-
ment, if any, that might be advantageous to the subject;
(5) A statement describing the extent, if any, to which confidentiality of
records identifying the subject will be maintained. In projects regu-
* FDA requirements differ slightly: omitting A. (d) and specifying the documenta-
tion required when informed consent is waived in emergency situations.
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lated by the Food and Drug Administration, subjects must be informed
that there is a possibility that their records may be inspected by the
FDA.
(6) For research involving more than minimal risk, an explanation as to
whether any compensation and an explanation as to whether any medi-
cal treatments are available if injury occurs and, if so, what they con-
sist of, or where further information may be obtained;
(7) An explanation of whom to contact for answers to pertinent questions
about the research and research subjects' rights, and whom to contact
in the event of a research-related injury to the subject; and
(8) A statement that participation is voluntary, refusal to participate will
involve no penalty or loss of benefits to which the subject is otherwise
entitled, and the subject may discontinue participation at any time
without penalty or loss of benefits to which the subject is otherwise
entitled.
(b) Additional elements of informed consent. When appropriate, one or more
of the following elements of information shall also be provided to each
subject:
(1) A statement that the particular treatment or procedure may involve
risks to the subject (or to the embryo or fetus, if the subject is or may
become pregnant) which are currently unforeseeable;
(2) Anticipated circumstances under which the subject's participation may
be terminated by the investigator without regard to the subject's con-
sent;
(3) Any additional costs to the subject that may result from participation
in the research;
(4) The consequences of a subject's decision to withdraw from the research
and procedures for orderly termination of participation by the subject;
(5) A statement that significant new findings developed during the course
of the research which may relate to the subject's willingness to continue
participation will be provided to the subject; and
(6) The approximate number of subjects involved in the study.
(c) An IRB may approve a consent procedure which does not include, or which
alters, some or all of the elements of informed consent set forth above, or
waive the requirement to obtain informed consent provided the IRB finds
and documents that:
(1) The research involves no more than minimal risk to the subjects;
(2) The waiver or alteration will not adversely affect the rights and welfare
of the subjects;
(3) The research could not practicably be carried out without the waiver
or alteration; and
(4) Whenever appropriate, the subjects will be provided with additional
pertinent information after participation.
(d) An IRB may approve a consent procedure which does not include, or which
alters, some or all of the elements of informed consent set forth above, or
waive the requirement to obtain informed consent provided the IRB finds
and documents that:
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(1) The research or demonstration project is to be conducted by or sub-
ject to the approval of state or local government officials and is de-
signed to study, evaluate, or otherwise examine:
(i) programs under the Social Security Act, or other public benefit
or service programs,
(ii) procedures for obtaining benefits or services under those pro-
grams,
(iii) possible changes in or alternatives to those programs or pro-
cedures, or
(iv) possible changes in methods or levels of payment for benefits or
services under those programs; and
(2) The research could not practicably be carried out without the waiver
or alteration.
(e) The informed consent requirements in these regulations are not intended to
preempt any applicable federal, state, or local laws which require addi-
tional information to be disclosed in order for informed consent to be
legally effective.
(f ) Nothing in these regulations is intended to limit the authority of a physician
to provide emergency medical care, to the extent the physician is permitted
to do so under applicable federal, state, or local law.
B. Consent and Assent Requirements for Research Involving Children
(a) In addition to the consent requirements described in A. above, the follow-
ing requirements apply to research involving children
:
(1) When children are subjects in research, solicitation of their assent as
well as the consent of their parents or guardians is normally required.
(See also Appendix IV, page 67 and Tables 6A and 6B, Criteria for
IRB Approval, pages 41 and 42.)
(2) "Assent" means a child's affirmative agreement to participate in re-
search. Mere failure to object should not, without affirmative agree-
ment, be construed as assent.
(3) The assent of the children is not required if:
(i) the IRB determines that the capability of some or all of the
children involved in research under a particular research protocol
is so limited that they cannot reasonably be consulted; or
(ii) the IRB determines that the intervention or procedures involved
in the research holds out a prospect of direct benefit that is im-
portant to the health or well-being of the children and is avail-
able only in the context of the research; or
(iii) the IRB determines that the circumstances permit consent to be
waived in accordance with A. (c), (d), and (f ) above.
(b) The consent and assent requirements described in A. and B. above may be
waived if:
(1) The IRB has determined that the research protocol is designed for
conditions or for a subject population for which parental or guardian
permission is not a reasonable requirement to protect the subjects
(for example, neglected or abused children), and,
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(2) The waiver is not inconsistent with federal, state, and local laws and
(3) An appropriate mechanism for protecting the children who will par-
ticipate as subjects in the research is substituted. (The choice of an
appropriate mechanism would depend upon the nature and purpose
of the activities described in the protocol; the risk and anticipated
benefit to the research subjects; and their age, maturity, status, and
condition.)
C. Consent Requirements for Research Involving Prisoners
(a) In addition to the consent requirements described in A. above, the fol-
lowing requirements apply to research involving prisoners:
Research on prisoners may be undertaken only if:
(1) Adequate assurance exists that parole boards will not take into ac-
count a prisoner's participation in the research when making decisions
regarding parole, and each prisoner is clearly informed in advance
that participation in the research will have no effect on his or her
parole; and
(2) Any possible advantages accruing to the prisoner through his or her
participation in the research, when compared to the general living con-
ditions, medical care, quality of food, amenities, and opportunity for
earnings in the prison, are not of such a magnitude that his or her
ability to weigh the risks of the research against the value of such
advantages in the limited choice environment of the prison is im-
paired.
D. Consent Requirements for Research Involving Pregnant Women and Fetuses
(a) In addition to the consent requirements described in A. above, the follow-
ing requirements apply to research involving pregnant women and fetuses:
(1) Research directed toward pregnant women may be conducted only
if the mother and father are legally competent and have given their
informed consent after having been fully informed regarding possible
impact on the fetus, except that the father's informed consent need
not be secured if:
(i) the purpose of the research is to meet the health needs of the
mother;
(ii) his identity or whereabouts cannot reasonably be ascertained;
(iii) he is not reasonably available; or
(iv) the pregnancy resulted from rape.
(2) Research directed toward fetuses in utero may be conducted only if
the mother and father are legally competent and have given their in-
formed consent, except that the father's informed consent need not be
secured if:
(i) his identity or whereabouts cannot reasonably be ascertained;
(ii) he is not reasonably available; or
(iii) the pregnancy resulted from rape.
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TABLE 2: HHS REQUIREMENTS* FOR INFORMED CONSENT
E. Documentation of Informed Consent
§ 46.117 Documentation of informed consent.
(a) Except as provided in paragraph (c) of this section, informed consent shall
be documented by the use of a written consent form approved by the IRB
and signed by the subject or the subject's legally authorized representative.
A copy shall be given to the person signing the form.
(b) Except as provided in paragraph (c) of this section, the consent form may
be either of the following
:
(1) A written consent document that embodies the elements of informed
consent required by §46.116. This form may be read to the subject or
the subject's legally authorized representative, but in any event, the
investigator shall give either the subject or the representative adequate
opportunity to read it before it is signed; or
(2) A "short form" written consent document stating that the elements of
informed consent required by §46.116 have been presented orally to
the subject or the subject's legally authorized representative. When this
method is used, there shall be a witness to the oral presentation. Also,
the IRB shall approve a written summary of what is to be said to the
subject or the representative. Only the short form itself is to be signed
by the subject or the representative. However, the witness shall sign
both the short form and a copy of the summary, and the person actually
obtaining consent shall sign a copy of the summary. A copy of the
summary shall be given to the subject or the representative, in addi-
tion to a copy of the "short form."
(c) An IRB may waive the requirement for the investigator to obtain a signed
consent form for some or all subjects if it finds either:
( 1 ) That the only record linking the subject and the research would be the
consent document and the principal risk would be potential harm re-
sulting from a breach of confidentiality. Each subject will be asked
whether the subject wants documentation linking the subject with the
research, and the subject's wishes will govern; or
(2) That the research presents no more than minimal risk of harm to sub-
jects and involves no procedures for which written consent is normally
required outside of the research context.
In cases where the documentation requirement is waived, the IRB
may require the investigator to provide subjects with a written state-
ment regarding the research.
(d) When children are included as subjects in the research, permission by
parents or guardians shall be documented in accordance with and to the
extent required by (a) through (c) above. When the IRB determines that
assent of the children is required, it shall also determine whether and how
assent must be documented.
* FDA requirements differ slightly: omitting E. (c) and specifying the documenta-
tion required when informed consent is waived in emergency situations.
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2. Confidentiality of Data
In all research involving human subjects, confidentiality of identifi-
able information is presumed and must be maintained unless the
investigator obtains the express permission of the subject to do other-
wise.
The University recognizes the rights of the subjects to be protected
against injury or illegal invasions of their privacy and their interests
as members of a free society in preserving their dignity. The more
sensitive the material, the greater the care that must be exercised in
obtaining, handling, and storing data. Ordinarily, the following re-
quirements must be met, subject only to their applicability to the
particular activity:
a. Questionnaires, inventories, interview schedules, and other data-
gathering instruments and procedures should be carefully designed
to limit the personal information to be acquired to that which is
absolutely essential to the activity.
b. Data that include information which would reveal a subject's
identity should be stored in files accessible only to the project
investigator and his or her authorized staff or representatives.
c. As early as feasible, the data should be handled in coded form, i.e.,
the subject's name and information that would reveal his or her
identity should be removed. Plans for the ultimate disposition of
the data should be made; or if they are to be retained indefinitely,
plans must be made for their continued security.
d. The identity of subjects must not be released except with their ex-
press permission.
e. Use of stored data or information, which was originally obtained
for different purposes and which involves identifiable subjects,
requires examination of the risk involved, a determination of
whether the new use is within the scope of the original consent or
whether obtaining additional consent is necessary and feasible, and
provision for the preservation of anonymity of the subjects.
Data that are part of the public domain are not covered by the
foregoing restrictions. (For research requiring prior review [see
Part III], the material submitted for review must specify the provi-
sions for maintaining the confidentiality of data and/or preserving
the anonymity of subjects.)
3. Classification of Risk and Required Safeguards
a. Types of Risk
There are different risks inherent in different research procedures.
Risk is most obvious in medical and behavioral science research
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projects involving procedures which may induce a potentially harm-
ful altered physical state or condition: surgical and biopsy proce-
dures; the removal of organs or tissues; the administration of drugs
or radiation; the use of indwelling catheters or electrodes; the re-
quirement of strenuous physical exertion; subjection to deceit, pub-
lic embarrassment, humiliation, or emotional stress.
There is a wide range of medical, social, and behavioral projects
and activities which pose no immediate physical risk to the subject,
e.g., those involving the use of personality inventories, interviews,
questionnaires, observation, photographs, taped records, and stored
data. However, some of these procedures may involve varying de-
grees of discomfort, harassment, or invasion of privacy, or they may
constitute a threat to the subject's dignity through the imposition
of demeaning conditions.
There are also medical and biomedical projects concerned solely
with organs, tissues, body fluids, and other materials obtained in
the course of routine performance of medical services, such as
diagnosis, treatment, and care. The use of these materials obviously
involves no element of physical risk to the subject. However, their
use for many research, training, and service purposes may present
psychological, social, or legal risks to the subject. In these cases, the
key questions are whether the circumstances under which the ma-
terials were procured were appropriate and whether adequate and
appropriate consent was, or can be, obtained for the use of these
materials for project purposes.
Some studies depend upon stored data or information which was
obtained for different purposes.
• If the materials to be used in the research involves identifiable
subjects, the assessment of the risk involved must include a de-
termination of whether the use of these materials is within the
scope of the original consent, whether consent is necessary, and
whether it can be obtained.
• If the material to be used in the research does not involve iden-
tifiable subjects, there.is no risk to the subjects.
Classification of Risks
The human subjects involved in research conducted at or sponsored
by the University of Illinois at Urbana-Champaign participate in
a great variety of research projects. They range from classroom
demonstrations where there are no risks beyond those associated
with customary everyday existence to experimental studies of drugs,
vaccines, radioactive materials, and severe physiological stresses
where there is a definite risk. For the purposes of safeguarding the
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human subjects and assuring that these safeguards are continuously
provided, two classifications of risk are introduced
:
i. Minimal Risk: The risks of harm anticipated in the proposed
research are not greater, considering probability and magnitude,
than those ordinarily encountered in daily life or during the
performance of routine physical or psychological examinations
or tests.
it. More Than Minimal Risk: The anticipated risks in the proposed
research exceed, either in probability or magnitude, those ordi-
narily encountered in daily life or during the performance of
routine physical or psychological examinations or tests.
All research protocols that involve procedures that may in-
duce potentially harmful, altered psychological or physical states
or conditions, untried diagnostic and surgical procedures or de-
vices; biopsy procedures; removal of organs or tissues for study,
reference, transplantation or banking; administration of drugs
or radiation; use of indwelling catheters or indwelling elec-
trodes; and procedures which require strenuous physical exer-
tion fall in this category.
Several examples of uses of human subjects are cited in
Tables 3 and 4, page 25, where the activities are classified ac-
cording to these two categories of risk. These examples, which
are merely illustrative, should serve as guides for the classi-
fication of future studies involving human subjects. In classifying
research involving human subjects, the investigator and those
who review the proposed use of subjects should not simply
attempt to identify the research with these particular examples,
but should follow the principles and procedures of this docu-
ment in arriving at a carefully reasoned decision.
Specific Safeguards According to Risk Classification
The two categories of risk above require different safeguards for
the rights and welfare of the subjects. Investigators, deans, direc-
tors, and department heads are responsible for assuring that these
safeguards are provided accordingly.
i. For Activities Involving No More Than Minimal Risk
• Participation must be voluntary; but signed, written consent
forms are not necessarily required.
• All subjects should be able to state that they have no disorder
or defect contraindicating their participation in the proposed
project. (Whether or not subjects are in fact asked to make
such a statement will depend upon the nature of the project.
)
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• The project must be supervised by a qualified faculty or staff
member who thereby assumes responsibility for the protection
of the human subjects.
if. For Activities Involving Greater Than Minimal Risk
• Participation must be voluntary and signed written consent
forms are considered mandatory, unless another method for
obtaining and documenting consent is specifically approved
by the Institutional Review Board.
• A written record of the research detailing the procedures em-
ployed and the results obtained shall be made and kept for
reference.
• The project must be supervised by a qualified faculty or staff
member who thereby assumes responsibility for the protection
of the human subjects.
• When the risk involved is a significant physical risk, the in-
vestigator and those who review his or her plans must deter-
mine:
— whether it will be necessary for the subjects' physical con-
dition to be evaluated by a licensed physician who is
acquainted with the possible hazards of the proposed in-
vestigations; and
— whether supervision or ready availability of a physician is
advisable for the project.
• No form of radioactive material may be experimentally ad-
ministered to human subjects without the authorization of
the persons responsible to the University for the appropriate
and safe use of radioactive material.
• No investigational new drugs (drugs not certified by FDA for
clinical use) nor significant risk devices (as defined in 21
CFR 812.3 [m]) may be administered or used without com-
pliance with the FDA requirements. The FDA requirements
include appropriate notification to the FDA, receipt of either
a waiver or permission from the FDA, and in the case of
drugs, an Investigations New Drug (IND) number; in the
case of a significant risk device, an Investigational Device
Exemption (IDE) number.
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TABLE 3: EXAMPLES OF RESEARCH INVOLVING
MINIMAL RISK
1. Studies of the psychological and physiological effects of mild to moderate
sleep loss.
2. Studies of movement and moderate exercise of asymptomatic children and
adults where adverse effects are not anticipated.
3. Classroom experiments on physiological responses to moderate exercise,
mild thermal stress, or breathing atmopheres with slightly reduced oxygen
or slightly elevated carbon dioxide, etc.
4. Most psychological studies of learning, conditioning, sensory perception,
personality, and group situations.
5. Psychological and judgment responses to speech.
6. Psychosocial studies of childhood obesity.
7. Behavioral studies of child development.
8. Corrective therapeutic exercise.
9. Industrial work studies with mild to moderate work load and mild to mod-
erate thermal stress.
10. Clothing and textile studies under conditions of mild to moderate thermal
stress.
11. Psychological studies of hypnosis where the subjects are not subjected to
physiological or emotional stress. In this context, the volunteer under hypno-
sis will not be asked personal questions which relate to his private life.
12. Nutritional studies in which the subjects are expected to ingest neither
unusual diets nor diets which are deficient in essential nutrients.
13. Taste panel studies and taste tests involving common food ingredients or
known, edible materials.
TABLE 4: EXAMPLES OF RESEARCH INVOLVING MORE
THAN MINIMAL RISK
1. Simulated high altitude flights.
2. Psychological studies of hypnosis where subjects are subjected to physiological
or emotional stress.
3. Adult exercise and fitness testing where the imposed work load substantially
exceeds the customary physical activity of the individual.
4. Industrial work studies where there is hard physical work and high environ-
mental temperature.
5. Physiological studies of sweating involving special nutrient regimens, dehydra-
tion, and work in thermally stressful surroundings.
6. Pharmacological studies of prescribed drugs.
7. Studies involving introduction of cold viruses or the administration of vaccines
and antibiotics.
8. Studies of the effects of prescribed tranquilizer drugs on driving skills.
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Part III: Review Requirements:
Applicability, Exemptions,
and Procedures
1. Research conducted at or sponsored by the University of Illinois at
Urbana-Champaign, whether subject to or exempt from prior review,
must:
a. adhere to the Belmont Principles,
b. be in compliance with the Nuremberg Code or one of the ethical
codes developed by the various professional associations, and
c. adhere to the policies and procedures set forth in this document.
All projects involving human subjects must observe the UIUC
standards of informed consent and confidentiality of data.
2. Investigators are encouraged to consult with their peers regarding
research protocols involving human subjects.
3. All research involving human subjects must be submitted for prior
review in accordance with the IRB policies and procedures (see Sec-
tion B which follows on page 35) unless the only involvement of human
subjects will comply fully with the criteria for one or more of the
exemption categories set forth in Section A which follows on page 28.
4. Only UIUC faculty (instructors, assistant professors, associate profes-
sors, and professors) are eligible to make the determination of com-
pliance with the exemption criteria. Visiting faculty, students, teach-
ing assistants, research assistants, research associates, and other staff
must have their judgments regarding eligibility for exemption re-
viewed by the faculty member who shall accept responsibility for that
decision.
5. The moral and legal burden of the protection of human subjects in
work involving research in the exempted categories lies with the re-
sponsible principal investigator, i.e., the qualified faculty or staff mem-
ber supervising the work.
6. Investigators may request review of exempted work and are encour-
aged to do so if they are uncertain about whether or not the project
qualifies for exemption or if they wish the advice of the Institutional
Review Board (333-2670)
.
7. The Institutional Review Board reserves the right to require review
of specific research activities or classes of research activities even
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though they qualify for exemption. Exercise of such oversight will
rarely be necessary. Requirements of sponsoring agencies, unexpected
problems, and the need to evaluate experiences with exemption cate-
gories might trigger such review.
Note: For HHS funded work, the submission of Form HHS-596
(Protection of Human Subjects Assurance/Certification/Declaration),
signed by the Executive Secretary of the IRB, is still required for all
research involving human subjects, whether it is exempt or not. For
work that is exempt
:
• check the last box in item 5 of the Certification Form, and
• enter the HHS identification number for the exemption claimed on
the line provided.
HHS identification numbers are given in the following list of ex-
emption categories (Section A)
.
HHS has warned that an inappropriate claim for exemption may
lead to delays in processing an application for funding.
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A. Exemption Criteria*
Research may be exempted from prior review if the only involve-
ment of human subjects will be in one or more of the following
categories and will not be excluded by the limitations for the spe-
cific category (s):
Exemption Category
1. HHS Identification 46.101 (b) 1
Research conducted in established
or commonly accepted educational
settings, involving normal educa-
tional practices such as
a. research on regular and special
education instructional strategies,
or
b. research on the effectiveness of
or the comparison among in-
structional techniques, curricula,
or classroom management meth-
ods.
2. HHS Identification 46.101(b) 2
Research involving the use of edu-
cational tests (cognitive, diagnostic,
aptitude, achievement) if informa-
tion taken from these sources is
recorded in such a manner that
subjects cannot be identified, either
directly or through the identifiers
linked to the subjects.
Subjects will be considered un-
identifiable if the investigator has
no way to link the data with indi-
vidual subjects.
Limitations
Such work can be exempted only if the
investigator believes that the research
protocol will place the subjects at no
more than minimal risk.
The consent of authorized school
official (s) can serve in lieu of consent
of the individual subjects, but consent
must be obtained in an appropriate way.
If subjects are children with the ca-
pacity to give assent, normally their as-
sent must also be solicited. (See Part
II, Section Dl, pages 12-16.)
Confidentiality of identifiable infor-
mation must be maintained without the
express permission of the subjects to do
otherwise. (See Part II, Section D2,
page 21.)
If the work is governed by HHS
regulations, this exemption does not ap-
ply to research involving prisoners or re-
search directed toward pregnant women
as subjects.
Such work can be exempted only if the
investigator believes that the research
protocol will place the subjects at no
more than minimal risk.
If the research is undertaken in a
commonly accepted educational setting,
the consent of authorized school offi-
cial (s) can serve in lieu of consent of
the individual subjects. Otherwise, con-
sent of the subjects or their authorized
representatives must be obtained. If sub-
jects are children with the capacity to
give assent, normally their assent must
also be solicited. (See Part II, Section
Dl, pages 12-16.)
If the work is governed by HHS reg-
ulations, this exemption does not apply
to research involving prisoners or re-
search directed toward pregnant women.
* Note: Only faculty members and IRB staff are eligible to make the determina-
tions of compliance with the exemption criteria.
For assistance in interpreting the categories and the limitations on their use, call
the IRB office at 333-2670.
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Exemption Category (Continued)
3. HHS Identification 46.101 (b)3
Research involving survey or inter~
view procedures,* except where all
of the following conditions exist:
a. responses are recorded in such a
manner that human subjects can
be identified, directly or through
identifiers linked to the subjects,
and
b. the subject's responses, if they
became known outside the re-
search, could reasonably place
the subject at risk of criminal or
civil liability or be damaging to
the subject's financial standing
or employability, and
c. the research deals with sensitive
aspects of the subject's own be-
havior, such as illegal conduct,
drug use, sexual behavior, or use
of alcohol.
NOTE: Such projects require prior re-
view only if all three conditions exist.
All research involving survey or in-
terview procedures is exempt, without
exception, when the respondents are
elected or appointed public officials or
candidates for public office.
Limitations (Continued)
Such work can be exempted only if the
investigator believes that the research
protocol will place the subjects at no
more than minimal risk.
Consent of the subject, or the sub-
ject's representative, is required. If sub-
jects are children with the capacity to
give assent, normally their assent must
also be solicited.
If the work is governed by HHS reg-
ulations, this exemption does not apply
to research involving prisoners or chil-
dren, or research directed toward preg-
nant women as subjects.
Confidentiality of identifiable infor-
mation must be maintained without the
express permission of the subjects to do
otherwise.
* The words survey and interview are defined as follows.
Survey: (n.) A sampling, or partial collection of facts, figures, or opinions taken
and used to approximate or indicate what a complete collection and analysis
might reveal.
Interview: (n.) A formal meeting in which a person or persons question, consult,
or evaluate another, or others; (v.t.) To have an interview with in order to
question, consult, evaluate, or seek information from.
The use of survey or interview procedures occurs in a wide variety of research
activities even though the terms survey or interview may not actually be used by
the investigators in describing their work. For example, (1) descriptive studies in
which the methodology is elicitation of linguistic data by the classical techniques
of linguistics, or (2) descriptive (as opposed to experimental) studies of cognitive
understanding, personality, social perception, affect, and attitude.
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Exemption Category (Continued)
4. HHS Identification 46.101 (b)
4
Research involving observation (in-
cluding observation by participants)
of public behavior, except where all
of the following conditions exist:
a. observations are recorded in such
a manner that human subjects
can be identified, directly or
through identifiers linked to the
subjects, and
b. the observations recorded about
the individual, if they became
known outside the research, could
reasonably place the subject at
risk of criminal or civil liability
or be damaging to the subject's
financial standing or employ-
ability, and
c. the research deals with sensitive
aspects of the subject's own be-
havior, such as illegal conduct,
drug use, sexual behavior, or use
of alcohol.
NOTE: Such projects require prior re-
view only if all three conditions exist.
Limitations (Continued)
Such work can be exempted only if the
investigator believes that the research
protocol will place the subjects at no
more than minimal risk.
The consent of the subjects is implied
by their presence in a public place. (See
Part II, Section Dl, pages 12-16.)
If the work is governed by HHS regu-
lations, this exemption does not apply
to:
a. research involving prisoners,
b. research involving children where
the investigator (s) participates in the
activities being observed, or
c. research directed toward pregnant
women as subjects.
The confidentiality of identifiable in-
formation must be maintained without
the express permission of the subjects
to do otherwise. (See Part II, Section
D2, page 21.)
5. HHS Identification 46.101(b)
5
Research involving the collection or
study of existing data, documents,
records, pathological specimens, or
diagnostic specimens, if these sources
are publicly available or if the in-
formation is recorded by the in-
vestigator in such a manner that
subjects cannot be identified, di-
rectly or through identifiers linked
to the subjects.
Such work can be exempted only if the
investigator believes that the research
protocol will place the subjects at no
more than minimal risk.
The requirement for consent of the
subjects is waived if the data, docu-
ments, records, or specimens, etc., are
publicly available. The authorization
of the custodian of the data, etc., can
serve in lieu of specific subject consent
for access to data, etc., which are not
publicly available. In such cases, the in-
vestigator must be satisfied that the
custodian is authorized to release the
data, etc., for research purposes.
If work is governed by HHS regula-
tions, this exemption does not apply to
research involving prisoners or for re-
search directed toward pregnant women.
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Exemption Category (Continued)
6. HHS Identification 46.101 (b)
6
Research and demonstration projects
which are conducted by or subject to
the approval of the Department of
Health and Human Services, and
which are designed to study, evalu-
ate, or otherwise examine
a. programs under the Social Secu-
rity Act, or other public benefit or
service programs
;
b. procedures for obtaining benefits
or services under those programs;
c. possible changes in or alterna-
tives to those programs or proce-
dures;
d. possible changes in methods or
levels of payment for benefits or
services under those programs.
Limitations (Continued)
Such work cannot be exempted if prior
review is specifically required by statute,
or if the Secretary of HHS determines
that a research or demonstration project
presents a danger to the physical, men-
tal, or emotional well-being of a par-
ticipant or subject of the research or
demonstration project.
If the work is governed by HHS regu-
lations, this exemption does not apply to
research involving prisoners or to re-
search directed toward pregnant women.
The UIUC requirement for informed
consent can be waived if:
a. the research could not be carried out
practicably without the waiver, and
b. the Secretary of HHS has not de-
termined that the project presents a
danger to a participant or subject.
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Exemption Categories A through I cannot be used for work
funded by HHS or other agencies which require adherence to FDA
or HHS regulations.
Exemption Category
Collection of: hair and nail clip-
pings, in a nondisfiguring manner;
deciduous teeth; and permanent
teeth if patient care indicates a
need for extraction.
Limitations
Such work can be exempted only if the
investigator believes that the subjects
involved are in good health and that
the research will not place the subjects
at more than minimal risk.
Consent of the subject or the subject's
representative must be obtained. If sub-
jects are children with the capacity to
give assent, normally their assent must
be solicited. (See Part II, Section Dl,
pages 12-16.)
Confidentiality of identifiable infor-
mation must be maintained unless the
express permission of the subject is
given to do otherwise. (See Part II,
Section D2, page 21.)
This exemption cannot be used for
work funded by HHS or other agencies
governed by HHS or FDA regulations.
B. Collection of excreta and external
secretions, including sweat, uncan-
nulated saliva, placenta removed at
delivery, and amniotic fluid at the
time of rupture of the membrane
prior to or during delivery.
Same as for Exemption Category A.
Recording of data from subjects
eighteen years of age or older using
noninvasive procedures routinely em-
ployed in clinical practice. This in-
cludes the use of physical sensors
that are applied either to the sur-
face of the body or at a distance
and do not involve input of matter
or significant amounts of energy into
the subject or an invasion of the
subject's privacy. It also includes
procedures such as weighing, test-
ing sensory acuity, electrocardiog-
raphy, electroencephalography, ther-
mography, detection of naturally
occurring radioactivity, diagnostic
echography, and electroretinography.
It does not include exposure to
electromagnetic radiation outside
the visible range (for example, X-
rays or microwaves )
.
Same as for Exemption Category A.
This exemption does not apply to
research involving pregnant women.
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Exemption Category (Continued)
D. Collection of blood samples by veni-
puncture, in amounts not exceeding
a total of four hundred fifty milli-
liters in an eight-week period, and
no more often than two times per
week from subjects eighteen years
of age or older who are in good
health and not pregnant.
E. Collection of both supra- and sub-
gingival dental plaque and calculus,
provided the procedure is not more
invasive than routine prophylactic
scaling of the teeth and the process
is accomplished in accordance with
accepted prophylactic techniques.
F. Voice recordings made for research
purposes such as investigations of
speech defects.
G. Moderate exercise by healthy vol-
unteers.
H. Research on individual or group
characteristics or behavior (such as
studies of perception, personality,
social interaction, affect or attitude)
which does not involve either of the
following
:
a. stress to the subjects, including
use or threat of noxious or aver-
sive stimuli, or
b. intentional, clearly nontransitory
alteration of the subject's emo-
tional state or behavior.
Limitations (Continued)
Same as for Exemption Category A.
Same as for Exemption Category A.
Same as for Exemption Category A.
Same as for Exemption Category A.
This exemption does not apply to
research involving pregnant women.
Such work can be exempted only if the
investigator believes that the subjects
involved are in good health and that
the research will not place the subjects
at more than minimal risk.
Consent of the subjects or the sub-
ject's representative must be obtained.
If subjects are children with the ca-
pacity to give assent, normally their as-
sent must be solicited. Note that decep-
tion is permitted only under certain
circumstances. (See Part II, Section Dl,
pages 12-16.)
Confidentiality of identifiable infor-
mation must be maintained unless the
express permission of the subjects is
given to do otherwise. (See Part II,
Section D 2, page 21.)
This exemption cannot be used for
work governed by HHS or FDA regu-
lations.
33
Exemption Category (Continued)
I. The study of existing data, docu-
ments, records, pathological speci-
mens, or diagnostic specimens if
the original collection of the data
would have been exempt under one
or more of the other exemption
categories described above.
Note: This exemption category is
an expansion of exemption category
5. If the investigator does not know
how the original data, etc., were
obtained, or if the research does not
fall within exemption category 5, it
must be submitted for prior review.
Limitations (Continued)
Such work can be exempted only if the
investigator believes that the research
will not place the original subjects at
more than minimal risk.
The consent of the subjects from
whom the data, documents, records, or
specimens were originally obtained is
waived if the data, etc., are publicly
available. The authorization of the cus-
todian of the data, etc., will serve in
lieu of specific subject consent for data,
etc., which are not publicly available. In
such cases, the investigator must be sat-
isfied that the custodian is authorized
to release the data, etc., for the research
purpose. Otherwise, consent of the sub-
jects must be obtained.
Confidentiality of identifiable infor-
mation must be maintained unless the
express permission of the subjects is
given to do otherwise. (See Part II,
Section D2, page 21.)
This exemption cannot be used for
work governed by HHS or FDA regu-
lations.
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B. Prior Review Process for Nonexempt Research
Much of the research undertaken at the University of Illinois at Urbana-
Champaign involves no more than minimal risk. A considerable amount
of the research involving human subjects here is undertaken without
external support. The University has developed a partially decentralized
process for review of research involving subjects where that research is
not externally funded and places the subjects at no more than minimal
risk.
Departments which have a large volume of research involving human
subjects which is neither externally funded nor involves research above
minimal risk have been invited to develop and submit for IRB approval
departmental guidelines for decentralized review of such work. Given
the satisfactory experience with this system for a period of six years, the
partially decentralized review procedures will be continued. Those de-
partments with approved guidelines must follow the revised IRB policies
and procedures given in this document. A list of departments which have
IRB approved guidelines is available from the office of the Institutional
Review Board (333-2670).
Research in departments which do not have IRB approved guidelines,
which involves external support, or which places subjects at more than
minimal risk must be submitted to the central Institutional Review Board
for prior review.
Table 5 summarizes the criteria which determine the locus of review.
Figure 1 summarizes the review process.
Results of reviews conducted by central IRB will be provided to the
Project Director in writing by the Executive Secretary of the IRB. Results
of reviews conducted by IRB-approved departmental review processes
will be communicated in accordance with departmental practice. For
further information, check with the Departmental Executive Officer.
If either the IRB review or IRB-approved departmental review process
results in the disapproval of or a major change in a research activity, the
review body will provide a written statement of the reasons for its decision
and will give the investigator an opportunity to respond either in person
or in writing. Actions of the IRB-approved departmental review process
may be appealed to the central IRB.
Note: Approvals by the central IRB or IRB-approved departmental
review process are valid for one year unless a shorter period is specified.
All research subject to prior initial review is subject to continuing review
requirements described in Section III, G, pages 45 and 46.
(Text continues on page 38.)
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TABLE 5: UIUC REVIEW REQUIREMENTS
Type of Research
1. Exempt research, that is research in
which the only involvement of human
subjects will comply fully with cri-
teria for one or more of the exempted
categories. (See Part III, page 26
and Section A, pages 28-34.)
Locus of Review
Responsible faculty investigator (Con-
sultation with colleagues encouraged;
IRB review available on request.)
2. All nonexempt research which is ex-
ternally funded, regardless of the
level of risk involved.
central Institutional Review Board
S. All nonexempt research which places
subjects at more than minimal risk,
regardless of the source of funds.
central Institutional Review Board
All nonexempt research in depart-
ments which do not have IRB-ap-
proved guidelines for decentralized
review, regardless of the level of risks
involved or the source of funds.
central Institutional Review Board
5. Research which meets all of the fol-
lowing requirements:
a. Is undertaken' in a department
which has IRB-approved guide-
lines for decentralized review, and
b. is not externally funded, and
c. does not place subjects at more
than minimal risk, and
d. is not exempt.
IRB-approved departmental review pro-
cedures
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FIGURE 1: THE REVIEW PROCESS FOR RESEARCH ACTIVITIES
Are human subjects
involved in research?
(See definitions of
subject and research
in Part II, p. 8 f«.)
No Uncertain Yes
I I
Proceed Contact
w ith IRB Office
research (3-2670)
Will Informed consent of
the subject or subject's
representative be obtained
in accordance wrth UIUC
policy? (See Part II, D 1,
pp. 12-16.)
No Uncertain Yes
Revise plans Contact
to comply irb Office
with UIUC (3-2670)
policy
j u
Does the research adhere to all
of following:
a) Belmont Principles and
b) Nuremberg Code or ethical code
of appropriate professional
association and
c) UIUC policies and procedures
for protection of human subjects?
(See Parts I and II of this document.)
Discussion with colleagues and/or
consultation with Institutional Review
Board is encouraged.
No
Revise research
design to comply
with these
requirements.
Is investigator a faculty member?
Have judgments on following questions been
validated by faculty member who will accept
responsibility for judgments?
Does the only involvement of human subjects satisfy fully all the
criteria for one or more of the exemption categories? (See Part
III, p. 26, and Section A, pp. 28-34.)
Nofe: Research involving more than minimal risk cannot be
exempted from prior review.
Yes
t
(Institutional Review Board
review optional)
Uncertain
I
Consult with
IRB staff
(3-2670)
No
Is the research
externally funded?
Proceed with research
No
I
Does the investigator's department
have IRB-approved guidelines?
Submit to central
Institutional Review Board
Yes
Does activity place subjects at
more than minimal risk?
1
No
I
Submit to Department
Departmental Review Process
Proceed with Investigator and
research* deP l - consult on
changes needed
Do not proceed
with research
Investigator and IRB
consult on changes needed
*Note: Approvals by the central IRB or IRB-approved departmental review process
are valid for one year, unless a shorter period is specified.
All research subject to prior initial review is subject to continuing review
requirements described in Section III, G.
C. Timing of Review
Review must occur prior to the initiation of activity and prior to imple-
mentation of changes in procedures involving human subjects (unless the
research is necessary to eliminate apparent immediate hazards to the hu-
man subjects) and at least annually during the lifetime of the project. If
the project is being proposed for external funding, review should take place
prior to or shortly after submission of the proposal to the funding agency.
Some funding agencies have imposed deadlines for submission of the
certification of IRB review and approval. For example, HHS has set a
deadline of 60 days after proposal submission. 1
1. Indefinite Plans
Certain types of research, particularly externally funded research, are
initiated with the knowledge that human subjects may be involved but
without definite plans at the time of research initiation or research
proposal submission. For example, institutional type grants where
selection of specific projects is the institution's responsibility; research
training grants where trainee activities involving subjects remain to
be selected; and projects in which the human subjects' involvement
will depend on completion of instruments, prior animal studies, or
purification of compounds, etc.
Proposals for research with indefinite plans involving use of human
subjects do not need prior review. Although such research may be
initiated and an award of external support may be made prior to the
development of definite plans for involving human subjects, no hu-
man subjects may be involved in any research until the project has
been reviewed and approved in accordance with IRB policies and
procedures. Funding agencies governed by the HHS regulations re-
quire that work with human subjects not be initiated until certifica-
tion of review has been submitted to the sponsor, unless the work is
exempt from prior review. (See Exemption Categories, Part III, Sec-
tion A, pages 28-31.)
1 For National Institutes of Health (NIH) applications, an HHS-596 Form must
be submitted with the application, unless institutional review is unavoidably de-
layed beyond submission of the application. In such a case, enter "Pending" on
the HHS-596 Form and provide an explanation. A follow-up HHS form must
then be submitted and received within 60 days after the receipt date for which
the application is submitted. Any modifications of the Research Plan section of the
application are to be submitted with the follow-up HHS-596 Form. Note: If certi-
fication is not received within the 60 day period, the application will be considered
incomplete and will be deferred for a later review. To assure receipt in time, pro-
vide the IRB office with the name of the initial review group (IRG) to which the
application has been assigned by NIH.
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2. Change from "No Human Subjects" to the "Use of Human Subjects"
Occasionally an investigator undertakes research without the intention
of involving subjects, but he or she later decides to use human sub-
jects in the research. Before work with human subjects can begin,
the research must be reviewed in accordance with IRB approved
policies and procedures. For work funded by agencies governed by
the HHS regulations, approval of the proposed change to use human
subjects must be given by the agency as well.
D. Expedited Review
Some categories of research that require review by the central Institu-
tional Review Board may be reviewed through an expedited review pro-
cedure. The Institutional Review Board will determine what specific
types of research are eligible for the expedited procedure and will restrict
its use to research involving no more than minimal risk. Work funded
by agencies governed by the HHS regulations will be eligible for the
expedited review provided that it meets the UIUC's IRB requirements
and also meets the HHS criteria for expedited review. The IRB may
also use the expedited review procedure to review minor changes in pre-
viously approved research during the period for which the original ap-
proval is authorized.
Research which meets the specific criteria for exemption in Part III,
Section A, but does not satisfy all of the limitations given for the specific
exemption category, may be eligible for expedited review unless the re-
search is governed by regulations which do not permit it. For example,
FDA regulations do not allow an expedited review for testing sensory
acuity in Exemption Category C or for any research in Exemption Cate-
gory H. (See pages 32 and 33.)
From the investigator's perspective, an expedited review will differ
from a regular review only in the length of time required for the review.
The same review materials must be submitted for an expedited review as
for a regular review and they should be directed to the same review body.
Under the expedited review procedure, the IRB review will be carried
out by specific IRB members assigned according to their expertise by the
Chairperson. The assigned reviewer will report the decision to the Exec-
utive Secretary. If the recommendation is for approval, the decision will
be communicated immediately to the investigator and will be reported at
the next IRB meeting. If the decision is for disapproval or a major
change, the proposed research will be placed on the agenda for full IRB
discussion.
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E. Criteria for IRB Approval of Nonexempt Research
These criteria apply whether the research is reviewed by the central In-
stitutional Review Board or under IRB-approved departmental guide-
lines. For work supported by agencies governed by the HHS regulations,
certain specific criteria are required in addition to those required by the
UIUC policy. Tables 6A and 6B give the UIUC criteria and the HHS
criteria.
The IRB staff will help identify other agency requirements.
F. Materials to Be Submitted for Prior Review
The materials submitted to the central Institutional Review Board or
the IRB-approved departmental review body must provide sufficient in-
formation for the reviewers to assure that the criteria for approval in
Tables 6A and 6B are met.
1. Form IRB-1
Form IRB-1, Information for Review of Research Involving Human
Subjects, must be submitted for all activities to be reviewed by the
central Institutional Review Board. Its use in departmental review of
nonexternally funded activities falling within IRB-approved depart-
mental guidelines is optional, but the information required for that
review must be presented in full. Form IRB-1 calls for administrative
information, certain classifying data, and responses to several specific
requests for information about the proposed research, the proposed
use of subjects, and provisions to assure protection of the rights and
welfare of the subjects.
The investigator's responses should be prepared with IRB readers
in mind. Answers should be brief and concise, but complete. The
materials submitted for review must demonstrate the investigator's
comprehension of the UIUC policies, standards, and procedures, and
his or her recognition of responsibility for the protection of human sub-
jects in research. Inadequate information causes delays in the review
process.
2. Additional Information
Certain types of projects require submission of special information
such as the following:
a. If subjects will include children, prisoners, pregnant women, or
fetuses, special care must be taken to describe plans for soliciting
consent/assent. For research involving children who are capable
of assent, the investigator should describe what the child will be
(Text continues on page 44.)
40
TABLE 6A: UIUC CRITERIA FOR IRB APPROVAL*
UIUC
The IRB shall review whether:
1. The proposed research is consistent with the Belmont Principles and the
Nuremberg Code, or one of the ethical codes of the professional associations,
and adheres to the UIUC policy stated in Part II of this document. (See
page 5 ff.
)
2. Risks to subjects are reasonable in relation to anticipated benefits, if any, to
the subjects and the importance of the knowledge that may be reasonably
expected to result.
In evaluating risks and benefits, the IRB should consider only those risks
and benefits that may result from the research (as distinguished from risks
and benefits of therapies subjects would receive even if not participating in
the research). The IRB should not consider possible long-range effects of
applying knowledge gained in the research (for example, the possible effects
of research on public policy) as among those research risks that fall within
the purview of its responsibility.
3. Selection of the subjects is equitable. In making this assessment, the IRB
should take into account the purposes of the research and the setting in
which the research will be conducted.
4. Informed consent will be sought from each prospective subject or the sub-
ject's legally authorized representative. If subjects are children and if they
are capable of giving assent, adequate provisions will be made to solicit their
assent as well as the permission of their parents or authorized representative.
Consent will be obtained in accordance with and to the extent required by
Section Dl of this document. (See page 12 ff.)
5. Informed consent will be appropriately documented, in accordance with, and
to the extent required by Part I, Section Dl, page 15 ff.
6. Where appropriate, the research plan makes adequate provision for monitor-
ing the data collected to ensure the safety of subjects.
7. Where appropriate, there are adequate provisions to protect the privacy of
subjects and to maintain the confidentiality of data. Unless subjects are ex-
pressly informed otherwise, confidentiality of records will be required.
8. Where some or all of the subjects are likely to be vulnerable to coercion or
undue influence, appropriate additional safeguards have been included in the
study to protect the rights and welfare of these subjects.
* See Table 6B for criteria applicable to research governed by HHS regulations.
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TABLE 6B: CRITERIA FOR IRB APPROVAL OF RESEARCH
GOVERNED BY HHS REGULATIONS
HHS
In order to approve research covered by these regulations, the IRB shall de-
termine that all of the following requirements are satisfied:
1. Risks to subjects are minimized:
a. by using procedures which are consistent with sound research design and
which do not unnecessarily expose subjects to risk, and
b. whenever appropriate, by using procedures already being performed on
the subjects for diagnostic or treatment purposes.
2. Risks to subjects are reasonable in relation to anticipated benefits, if any, to
subjects, and the importance of the knowledge that may reasonably be ex-
pected to result.
In evaluating risks and benefits, the IRB should consider only those risks
and benefits that may result from the research (as distinguished from risks
and benefits of therapies subjects would receive even if not participating in
the research). The IRB should not consider possible long-range effects of
applying knowledge gained in the research (for example, the possible effects
of the research on public policy) as among those research risks that fall
within the purview of its responsibility.
3. Selection of subjects is equitable. In making this assessment, the IRB should
take into account the purposes of the research and the setting in which the
research will be conducted.
4. Informed consent will be sought from each prospective subject, or the
subject's legally authorized representative, in accordance with and to the
extent required by Section 46.116, HHS regulations. (See Table 1, pages
16-19 of this document.) If subjects are children and if they are capable of
giving assent, adequate provisions will be made to solicit their assent as
well as the permission of their parents or authorized representative. (See
items 9 through 1 3 below.
)
5. Informed consent will be appropriately documented, in accordance with and
to the extent required by Section 46.117 of HHS regulations. See Table 2,
page 20 of this document.
)
6. Where appropriate, the research plan makes adequate provision for moni-
toring the data collected to ensure the safety of subjects.
7. Where appropriate, there are adequate provisions to protect the privacy of
subjects and to maintain the confidentiality of data.
8. Where some or all of the subjects are likely to be vulnerable or coercion or
undue influence, such as persons with acute or severe physical or mental
illness or persons who are economically or educationally disadvantaged, ap-
propriate additional safeguards have been included in the study to protect
the rights and welfare of these subjects.
9. When children are included in any research:
a. Adequate provisions are made for soliciting the assent of children and
the permission of their parents or guardians as set forth in Table 1. (See
page 18.)
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The IRB will judge whether children are capable of providing assent,
taking into account the ages, maturity, and psychological state of the
children involved and will determine how assent must be documented.
b. Where parental permission is required, the IRB will determine when
permission of one parent is sufficient, in accordance with HHS require-
ments described in Appendix IV, Section A, 1-b.
The IRB will determine when the assent and consent requirement
may be waived, in accordance with HHS consent requirements listed in
Table 1, pages 17-19.
10. When children are included in research in which more than minimal risk
is presented by an intervention or procedure that holds out the prospect
of direct benefit to the individual subject or by a monitoring procedure that
is likely to contribute to the subject's well-being,
a. the risk is justified by the anticipated benefit to the subjects, and
b. the relation of the anticipated benefit to the risk is at least as favorable
to the subjects as that presented by available alternative approaches.
11. When children are included in research in which more than minimal risk
to children is presented by an intervention or procedure that does not hold
out the prospect of direct benefit to the individual subject or by a moni-
toring procedure that is not likely to contribute to the well-being of the
subject,
a. the risk represents a minor increase over minimal risk;
b. the intervention or procedure presents experiences to subjects that are
reasonably commensurate with those inherent in their actual or ex-
pected medical, dental, psychological, social, or educational situations;
and
c. the intervention or procedure is likely to yield generalizable knowledge
about the subjects' disorder or condition that is of vital importance for
the understanding or amelioration of the subjects' disorder or condition.
12. When children are included in plans for research not otherwise approvable,
a. the IRB must find that the research presents a reasonable opportunity to
further the understanding, prevention, or alleviation of a serious prob-
lem affecting the health or welfare of children, and
b. the Secretary of HHS after consultation with a panel of experts in
pertinent disciplines (e.g., science, medicine, education, ethics, law)
and following an opportunity for public review and comment, must de-
termine either that the research in fact is approvable by the IRB or
i. the research presents a reasonable opportunity to further the under-
standing, prevention, or alleviation of a serious problem that affects
the health or welfare of children; and
ii. the research will be conducted in accordance with sound ethical
principles; and
iii. adequate provisions are made for soliciting the assent of children and
the permission of their parents or guardians.
13. When children who are wards of the state or any other agency, institution,
or entity are included in research
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a. involving more than minimal risk and no prospect of direct benefit to
individual subjects, but likely to yield generalizable knowledge about
the subjects' disorder or condition, or
b. not otherwise approvable which presents an opportunity to understand,
prevent, or alleviate a serious problem affecting the health or welfare
of children, the IRB must determine that the research is
i. related to their status as wards or
ii. conducted in schools, camps, hospitals, institutions, or similar settings
in which the majority of children involved as subjects are not wards
and the IRB will require the appointment of an advocate for each child
who is a ward. All other determinations required for research must also be
made. (See above.)
told about the research, how the information will be presented to
him or her, and how assent will be solicited. The information
presented to the child will vary from a simple description of what
the child will experience to the equivalent of the information that
would be presented to an adult subject. Younger and less sophisti-
cated children will be given simple information on what they will
experience as they participate in the research. For older and more
sophisticated children, more detailed information will be given,
together with a statement that the project is for the purpose of
research. All children must be informed that they may withdraw
from participation at any time.
b. If a written consent form or written explanation of the project is
used, submit a copy of a sample form or explanation.
c. If any initial deception is involved to avoid invalidation or biasing
of the research, indicate what information will be withheld and
why incomplete disclosure is justified. Also describe the debriefing
procedure to be used, if any.
d. If subjects are to receive payment or other incentives for participa-
tion, describe such incentives.
e. If access to subjects is gained through cooperating institutions not
under the control of the University, identify the institutions and
describe the method for assuring that the authorized official of that
institution is informed of the study. (If such subjects are placed
at more than minimal risk, documentation of the institutional ap-
proval will be required. See k below.)
Projects which place subjects at more than minimal risk require ihe
following additional information:
/. State the justification for use of human subjects.
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g. Provide the basis for the investigator's assessment of benefits, risks,
and adequacy of precautions taken to minimize risks. (Citation of
relevant prior work is helpful.)
h. Attach copies of sample consent forms to be used and any written
or oral explanation to be given to the subjects. If the project pre-
sents risks of physical injury, the consent form must include a state-
ment as to whether any compensation or medical treatment is
available if injury occurs, and, if so, what they consist of and where
further information may be obtained.
i. If drugs are to be administered, identify the drug, indicate whether
or not it is FDA-certified for this purpose; state the dosage to be
administered, who will administer the drug, the period of admin-
istration, and the anticipated effects. If the drug is not FDA-certi-
fied for this purpose, submit a copy of FDA Form 1571, Investiga-
tional New Drug Certification.
;. If a significant risk device is to be used, identify the device and
whether or not it is FDA approved for this purpose; state the pro-
visions for the use of the device, who will administer it, the period
of administration, and the anticipated effects. If the device has not
been approved by the FDA for this purpose, submit a copy of an
Investigational Device Exemption (IDE) Application which has
been sent to the Food and Drug Administration.
k. Document institutional authorization for access to subjects if access
to subjects is gained from a cooperating institution (provide status
of subjects; number of subjects; age range of subjects; name and
address of cooperating institution; name of authorizing official of
cooperating institution ; title, official signature, and telephone num-
ber of authorizing official)
.
In summary, the materials submitted for review must be presented in
sufficient detail for the IRB or IRB-approved departmental reviewers to
make a fair and responsible independent judgment as to the protection
provided for the subjects and the project's compliance with UIUC poli-
cies, standards, and procedures as well as applicable laws and regulations
of external agencies.
G. Continuing Review
The IRB and the IRB-approved departmental review bodies will conduct
a continuing review of nonexempt research at intervals appropriate to the
degree of risk, but no less frequently than once per year. The review in-
terval will be specified in the notification to the investigator regarding
the results of the initial review. The minimum requirements for a contin-
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uing review will include an inquiry regarding the investigator's plans for
continuing the research beyond the original period, modifications to the
original protocol, occurrence of any problems involving human subjects,
and consideration of the applicability of any changes in external or UIUC
review requirements. The IRB may also impose special requirements in
specific cases, such as a requirement for a progress report, third party re-
view of the consent process, or third party review of the research. Such
specific requirements will normally be stipulated in the original approval
letter.
Although the investigator is responsible for initiating the annual con-
tinuing review, the IRB or departmental review process should normally
provide a reminder of the necessity for continuing review and any forms
to be used for this purpose.
H. Review of Cooperative Research
Cooperative projects may involve distribution of responsibility for aspects
of the research or distribution of access to subjects among cooperating
investigators and/or institutions. UIUC policies and procedures must be
followed for all aspects of cooperative research which are conducted at
or sponsored by the University of Illinois at Urbana-Champaign. Where
the work is externally sponsored, the external sponsor's requirements must
be followed by every investigator and institution receiving such external
support. When the UIUC is the prime grantee or contractor, the UIUC
is responsible to the sponsor for safeguarding the rights and welfare of the
human subjects.
The UIUC may use joint review, reliance upon the review of another
qualified IRB, or similar arrangements to avoid duplication of effort. Such
special arrangements must be made well in advance through consultation
with the Executive Secretary of the IRB.
I. Records of Review
The review of nonexempt research must be documented. These records
must be retained for three years after the completion of the research.
They must be accessible for inspection and copying by authorized repre-
sentatives of the University or the sponsoring agencies.
1 . Records to be retained by IRB or IRB-approved departmental review
group
:
a. Materials submitted for review
b. Identity of reviewer(s)
c. Actions taken and basis for requiring changes or disapproval
d. Record of continuing review activities
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e. Correspondence between investigator and review body
/. Written guidelines for operation of the review body
g. Statements of significant new findings provided to subjects, where
required
2. Records to be retained by investigator:
a. Copies of signed consent documents (see also pages 15 and 16)
b. Written record of the research detailing the procedures employed
and the results obtained
J. Suspension or Termination of IRB Approval of Research
The central IRB has the authority to suspend or terminate approval of
any research conducted at or sponsored by the University of Illinois at
Urbana-Champaign that is not being conducted in accordance with the
IRB's requirements or that has been associated with unexpected serious
harm to subjects. Any suspension or termination of approval will include
a statement of the reasons for the IRB's action and shall be reported
promptly to the investigator and the appropriate institutional officials.
For any HHS supported work so terminated, HHS regulations require
that the Secretary of HHS be notified as well.
K. Institutional Oversight
Research that has been approved by the IRB may be subject to further
appropriate review and approval or disapproval by officials of the insti-
tution. Institutional officials may not approve the research if it has been
disapproved by the IRB.
Research that has been approved by an IRB-approved departmental
review process may be subject to further appropriate review and approval
or disapproval by the central IRB and/or officials of the institution.
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Part IV: Distribution of Responsibility
The responsibility for the protection of subjects in research is distributed
among several parties: principal and coprincipal investigators, depart-
ment heads and departmental review bodies, the Institutional Review
Board, the University administration, sponsoring agencies, the subjects
themselves, and those who control access to subjects.
A. Principal Investigator
The primary responsibility for the day-to-day assurance for protection
of the rights and welfare of human subjects lies with the individual re-
sponsible for the conduct of the activity, i.e., the principal investigator.
Specifically, the investigator is responsible for:
• Careful research design
• Careful adherence to ethical codes and applicable policies and proce-
dures of the UIUC, the sponsoring agency, and cooperating institu-
tions, if any
• Training and supervision of staff and students participating in the re-
search
• Providing information required and taking all steps in initial and con-
tinuing review of nonexempt research
• Retaining required records
• Obtaining prior approval of IRB (or IRB-approved departmental re-
view body) for changes in a nonexempt research activity
• Prompt reporting to the IRB of unanticipated problems involving risks
to subjects or others
B. Departmental Executive Officer
The Executive Officer of the department has the responsibility to:
• Assure that faculty, staff, and students are kept informed of the UIUC
policy and procedures and of their responsibilities for protecting the
rights and welfare of human subjects involved in research
• Assure that the departmental review process, if any, operates within
IRB-approved guidelines
• Assure that for any course offered by the department in which partici-
pation of the registrants as human subjects is expected, notification to
this effect is given in the course description in the official University
bulletins and timetables
• Report promptly to the IRB any unanticipated problems involving risks
to subjects or others
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C. Institutional Review Board and IRB-Approved
Departmental Review Bodies
The IRB and IRB-approved departmental review bodies are responsible
for:
• Initial and continuing review of nonexempt research
• Ascertaining acceptability of proposed research in terms of institutional
commitments, applicable law, and standards of professional conduct
and practice
• Documentation of such review in conformity with applicable law, reg-
ulations, and policies
• Provision of advice and counsel to investigators engaged in research
involving human subjects
In addition, the IRB has responsibilities for:
• Developing policy, procedures, information, and instructions
• Adjudication of differences and review of problems arising in research
involving human subjects
• Assuring compliance with externally imposed policies and regulations
• Reporting to the Executive Secretary unanticipated problems involving
risks to subjects and others in work funded by HHS
• Reporting to the appropriate institutional officials and, for research
funded by the HHS regulations, to the Secretary of HHS, any serious
or continuing noncompliance by investigators with the requirements
and determinations of the IRB
D. Sponsoring Agencies
Sponsoring agencies usually accept responsibility for evaluating research
proposed for their support. This evaluation is undertaken in addition to
that provided locally. The agency may impose additional conditions prior
to or at the time of funding if additional conditions are judged to be
necessary for the protection of human subjects. Furthermore, the agency
may require that its funding for any project be terminated or suspended
if it finds that the institution has materially failed to comply with the
terms of its regulations.
E. Subjects
Subjects who participate in research should
:
• Consider carefully the decision to participate in research
• Ask questions freely
49
• Recognize that they are free to withdraw from participation at any
time
• Notify the investigator promptly of adverse effects of participation
• Take unresolved complaints or concerns about their participation in
research to the Executive Officer of the Department and, if the matter
remains unresolved, to the Executive Secretary of the Institutional Re-
view Board
F. Individual or Institution Providing Access to Subjects
If the individual responsible for conduct of the activity is not a UIUC
employee or student but is obtaining access to subjects through UIUC,
the individual providing access to the subjects is responsible for assuring
that UIUC policies and procedures, including review requirements, are
met.
If professional practitioners or service agencies provide access to sub-
jects, the individual providing access should assure that the professional's
commitments to the client are not abridged.
If access is obtained through cooperating institutions, the authorized
official of the institution must be informed of the research and should
satisfy himself or herself that the subjects' rights and welfare will be pro-
tected and that institutional commitments to the subjects will not be
abridged.
50
Part V: Administration of the UIUC
Policies and Procedures
The UIUC principles for responsible use of human subjects in research,
formulated in 1964, were originally administered in a totally decentralized
manner consistent with the relatively low level of such activities and the
decentralized nature of the institution. Over the years, the increase in
the level of such activities and the increasing specificity of sponsored
agencies' regulations made a totally decentralized administration unwork-
able. In 1975, a central Institutional Review Board was established and
responsibility for assurance of the protection of human subjects was
placed on that body. The Institutional Review Board developed a mech-
anism for sharing the review task in order to accommodate the very
large number of projects which posed no more than minimal risk to the
subjects. The partially decentralized review strengthens the disciplinary
expertise of the review and enhances the accountability for protection of
subjects. The Institutional Review Board and the IRB-approved depart-
mental review bodies are described below.
A. The UIUC Institutional Review Board
The Institutional Review Board serves as the primary locus of institu-
tional authority and responsibility for activities involving the use of
human subjects. Its responsibilities include
:
• Development of policy and procedures for review of such activities
• Development of information and instructions for investigators, review-
ers, and subjects involved with such activities
• Initial and continuing review of such activities
• Ascertaining acceptability of proposed research in terms of institutional
commitments, applicable law, and standards of professional conduct
and practice
• Documentation of review of such activities in conformity with appli-
cable law, regulations, and policies
• Provision of advice and counsel to investigators engaged in such activi-
ties
• Adjudication of differences and review of problems arising out of such
activities
• Assuring compliance with externally imposed policies and regulations
• Reporting to the Secretary of HHS unanticipated problems involving
risks to subjects and others, in work funded by HHS
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• Reporting to the appropriate institutional officials and, for research
funded by the HHS regulations, to the Secretary of HHS, any serious
or continuing noncompliance by investigators with the requirements
and determination of the IRB
As such, it serves the needs of a complex institution and is able to
assure that externally imposed regulations are followed.
1 . Composition of the IRB and Selection of Its Members
The UIUC Institutional Review Board shall have at least five mem-
bers with varying backgrounds to promote complete and adequate
review of research activities commonly conducted by the institution.
Members will be chosen so that the Institutional Review Board will
be sufficiently qualified to:
• promote respect for its advice and counsel in safeguarding the rights
and welfare of human subjects and
• ascertain the acceptability of proposed research in terms of institu-
tional commitments in regulations, applicable law, and standards
of professional conduct in practice.
The following factors will be considered in selecting members
:
• experience and expertise and
• diversity of background, including consideration of the racial and
cultural background and sensitivity to such issues as community
attitudes.
The IRB will include both men and women as members; members
of more than one profession; at least one member whose primary con-
cerns are in nonscientific areas; and at least one member who is not
otherwise affiliated with the institution and who is not part of the
immediate family of a person who is affiliated with the institution.
If the IRB regularly reviews research that involves a vulnerable
category of subjects, (such as children, pregnant women, prisoners,
or the institutionalized mentally disabled), the IRB will include one
or more individuals who are primarily concerned with the welfare of
these subjects.
Each member of the IRB will have a designated alternate. Both
members and alternates will serve staggered three-year terms. Both
members and alternates are responsible for being informed on all IRB
policies and procedures and the applicable laws and regulations. The
IRB members are expected to review all the cases as well as to attend
and to vote at the meetings of the IRB. The alternates are encouraged
to review all the cases, to attend the meetings, and to participate in the
discussions; but they may not vote unless their designated member
is absent.
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Members and alternates are appointed by the Vice Chancellor for
Research after consultation with the Executive Secretary of the Insti-
tutional Review Board.
2. Operation of the IRB
The IRB meets regularly, normally at least monthly, to review pro-
posed and continuing activities involving human subjects and to
carry out its various responsibilities. A quorum is defined as a simple
majority of the number of members of the IRB. For review of research
governed by HHS regulations, the IRB quorum must include at least
one member whose primary concerns are in nonscientific areas. No
member or alternate shall be involved in either the initial or continu-
ing review of activity in which he or she has a conflicting interest, ex-
cept to provide information requested by the Board.
The Institutional Review Board will adopt a variety of mechanisms
to assure depth and breadth of review, including the use of primary
and secondary reviewers; a track system to group activities with simi-
lar levels of complexity; and a provision for inviting individuals with
competence in special areas to assist in the review of complex issues
which require expertise beyond or in addition to that available on
the IRB. In addition, the IRB may invite principal investigators to
attend the Institutional Review Board meeting for first-hand discus-
sion with the Board.
The Board will determine that the criteria for IRB approval are
met and will recommend the frequency of continuing review and the
nature and extent of any monitoring of the research or consent process
to be required. See Part III, Tables 6A and 6B, pages 41-44.)
In order for work to be approved by the IRB, it shall receive the
approval of a majority of those members present at the meeting.
The Board will provide for expedited review of certain categories
of research which it will designate with due consideration of appli-
cable regulations of sponsoring agencies. Under the expedited review
procedure, IRB review will be carried out by specific IRB members
assigned according to their expertise. The assigned reviewer will re-
port his or her recommendation to the Executive Secretary. If the rec-
ommendation is for approval, the decision will be communicated im-
mediately to the investigator and will be reported at the next IRB
meeting. If the decision is for disapproval or a major change, the
proposed research will be placed on the agenda for full IRB discus-
sion.
For work governed by HHS regulations, expedited review will only
be available for categories listed in the HHS regulations and for minor
changes in previously approved research during the period of valid ap-
proval.
53
The Board will provide written notice to principal investigators of
the disposition of their proposals. If the proposal is approved, the
letter will include the period for which the approval is valid, the
requirements for reporting any emergent problems involving human
subjects, the requirement for prior review in changes in procedures,
and any other special terms and conditions. If the Board stipulates
changes or if it disapproves the proposal, the written notification will
state the basis for this decision.
The IRB is responsible for the continuing review system described
in Part III, Section G. The IRB may undertake site visits, interviews,
or other methods for monitoring the conduct of research and consent
processes.
The Board will maintain adequate documentation of all IRB activi-
ties, including minutes of the IRB meetings. These minutes will be
kept in sufficient detail to show attendance at the meetings, actions
taken by the IRB, the vote on the actions, the basis for requiring
changes in or disapproval of research, and a written summary of the
discussion of controverted issues and their resolution. Other records
kept by the IRB are discussed in Part III, Section I.
B. IRB-Approved Departmental Review Bodies
A large number of activities involving human subjects at no more than
minimal risk are undertaken each year without external funding. Some
are part of introductory and research methods courses, some are short-
term pilot projects, doctoral dissertations, and independent study proj-
ects. Some are regular faculty research projects. The large volume of such
activities, the fact that subjects experience no more than the risks of
ordinary life, and the fact that for many the time available for review
is extremely short, all dictate that review must be expeditious and simple
as well as responsible.
Departments with a significant number of such activities are encouraged
to develop departmental guidelines on the basis of recurring types of
minimal risk activities undertaken by the department and the well-estab-
lished and accepted professional procedures used in the department. Such
guidelines must comply with the UIUC policies, standards, and pro-
cedures. When such guidelines have been approved by the Institutional
Review Board, the departmental review process may be used for non-
exempt research involving human subjects which:
• are not externally funded,
• fall within the departmental guidelines, and
• place subjects at no more than minimal risk.
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The departmental review body may refer any activity to the central
IRB for review. When it receives proposals for research which do not
fit within the departmental guidelines, it must refer the research to the
central IRB. Furthermore, an investigator may appeal a departmental
review body's disapproval to the Institutional Review Board.
Departments which elect to establish departmental review procedures
must document the review and retain records sufficient to allow the IRB
to review the department's experience with the decentralized review
process. Such reviews will normally be undertaken annually and will in-
volve an audit of a sample of cases reviewed at the departmental level.
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Appendix I: Bibliography of Ethical Codes
The Declaration of Helsinki: Recommendations Guiding Doctors in Clinical Re-
search, adopted by World Medical Association in 1964
American Medical Association
535 North Dearborn Street
Chicago, IL 60610
Professional Ethics: Statements and Procedures of the American Anthropological
Association (September, 1973)
American Anthropological Association
1703 New Hampshire Avenue, NW
Washington, DC 20009
Patients' Bill of Rights (November 17, 1972)
American Hospital Association, Inc.
840 North Lake Shore Drive
Chicago, IL 60611
AMA: Principles of Medical Ethics including "Ethical Guidelines for Clinical
Investigation" in Current Opinions of the Judicial Council of the American Med-
ical Association (1981)
American Medical Association
535 North Dearborn Street
Chicago, IL 60610
Human Rights Guidelines for Nurses in Clinical and Other Research (1975)
American Nurses' Association, Inc.
2420 Pershing Road
Kansas City, MO 64108
Ethical Standards (1981)
American Personnel and Guidance Association
5203 Leesburg Pike
Falls Church, VA 22041
Ethical Principles in the Conduct of Research with Human Participants (copyright
1973)
American Psychological Association, Inc.
1200 Seventeenth Street, NW
Washington, DC 20036
Ethical Principles of Psychologists (1981 Revision)
American Psychological Association, Inc.
1200 Seventeenth Street, NW
Washington, DC 20036
Code of Ethics of American Sociological Association (September 1, 1971)
American Sociological Association
1722 N Street, NW
Washington, DC 20036
Code of Ethics of the National Association of Social Workers (1979)
National Association of Social Workers, Inc.
1425 H Street, NW, Suite 600
Washington, DC 20005
56
Ethical Standards for Research with Children
Society for Research in Child Development
University of Chicago Press
5801 Ellis Avenue
Chicago, IL 60637
Copies of these publications are available for review in the office of the Executive
Secretary of the Institutional Review Board, Room 125 Coble Hall, and in the
University Library. Copies may be obtained from the addresses given above.
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Appendix II: Examples of Consent Forms
CONSENT FORM
EXAMPLE la
FOR A PROJECT AT MORE THAN
MINIMAL RISK
Required Elements4,
Identification of Project
Consent
Purpose
Procedures
Risks and/or
Discomforts
Benefits
Opportunity to Ask
Questions
Freedom to Withdraw
Name, Address, and
Phone Number of
Investigator
Signature of Subject
Date
CONSENT TO PARTICIPATE IN RESEARCH
"The Effects of Sleep Deprivation on Motor Control and
Response Time Tasks"
I state that I am over eighteen years of age, in good physical
health, and wish to participate in a program of research
being conducted by Freda Smith of the UlilC Psychology
Department.
The purpose of the research is to measure the effects
of prolonged sleep loss on motor control and response
time tasks.
The experimental procedures involve three sessions four
weeks apart during which I will be asked to go without sleep
for periods of 24 to 48 hours. I will not know the length
of the sleepless period ahead of time. At various times
during the sleepless period I will be asked to perform various
simple tasks and to respond to sounds or lights by pushing a
button.
I understand that there will be a responsible staff member
present at all times after the first twelve hours. I
understand that my blood pressure, respiration, and pulse
rate will be checked during the experiment.
I understand that as a result of sleep loss I may experience
extreme tiredness, feelings of disorientation, slight
depression, irritability, and sleep disturbances over a short
period of time. I understand that there are normally no long
term effects associated with the periods of sleeplessness
involved in this experiment.
1 understand that the experiment is not designed to help
me personally, but that the investigator hopes to learn about the
relationship between sleep loss and the ability to
perform tasks like those needed for the safe operation of
machinery and cars. I understand that I am free to ask
questions or to withdraw from participation at any
time.
In the event of physical injury resulting from participation
in this study, I understand that immediate medical treatment
is available at the McKinley Health Service. I also
understand that the University of Illinois will not provide
compensation for any injury sustained as the result of
participation in this research except as required by law.
Freda Smith, Responsible Principal Investigator
Albert Nicholas, Research Assistant
415 Psychology Building, Phone: 333-0110
Signature of Research Subject
Bale"
* The elements required for informed consent are listed to the left of the Consent Form itself to indi-
cate the location of each element in this particular example. For research governed by the regula-
tions of the U.S. Department of Health and Human Services or the Food and Drug Administration
additional elements may be required; see Part II, Tables 1 and 2, pages 16-20.
CONSENT FORM
EXAMPLE lb
SHORT FORM OF CONSENT FOR PROJECT
AT MORE THAN MINIMAL RISK
WRITTEN SUMMARY OF WHAT IS PRESENTED
ORALLY TO SUBJECTS (PART 1)
Required Elements*
Identification ot Project
Purpose
Procedures
Risks and/or Discomforts
Benefits
Opportunity to Ask Questions
Freedom to Withdraw
Signatures:
Staff Member
Witness
Date
Name, Address, and
Phone Number of
Investigator
"The Effects of Sleep Deprivation on Motor Control and
Response Time Tasks"
Subjects will be over eighteen years of age and 1n good
physical health.
The purpose of the research is to measure the effects
of prolonged sleep loss on motor control and response time
tasks.
The experimental procedures involve three sessions, four weeks
apart, during wh'ch subjects will be asked to go without
sleep for periods of 24 to 48 hours. Subjects will not
know the length of the sleepless period ahead of time. At
various times during the sleepless period subjects will be
asked to perform various simple tasks and to respond to sounds
or lights by pushing a button.
There will be a responsible staff member present at all times
after the first twelve hours. Subjects' blood pressure,
respiration, and pulse rate will be checked during the experiment.
As a result of sleep loss, subjects may experience
extreme tiredness, feelings of disorientation, slight
depression, irritability, and sleep disturbances over a short
period of time. Normally no long-term effects result from
the periods of sleeplessness involved in this experiment.
The experiment is not designed to help subjects
personally, but the investigator hopes to learn about the
relationship between sleep loss and the ability to perform
tasks like those needed for the safe operation of machinery
and cars. Subjects are free to ask questions and to
stop participating at any time.
In the event of physical injury resulting from participation
in this study, immediate medical treatment is available at
the McKinley Health Service. The University of Illinois
will not provide compensation for any injury sustained as
the result of participation in this research except as
required by law.
Signature of Staff Member
Signature of Witness to Explanation
Date
Freda Smith, Responsible Principal Investigator
Albert Nicholas, Research Assistant
415 Psychology Building
Phone: 333-0110
* The elements required for informed consent are listed to the left of the Consent Form itself to indi-
cate the location of each element in this particular example. For research governed by the regula-
tions of the U.S. Department of Health and Human Services or the Food and Drug Administration
additional elements may be required; see Part II, Tables 1 and 2, pages 16-20.
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CONSENT FORM
EXAMPLE lb
SHORT FORM OF WRITTEN CONSENT
(PART 2)
Required Elements*
Consent
Identification of Project
Explanation Has
Been Provided
Opportunity to Ask
Questions and Freedom to
Withdraw
Signatures:
Date
Staff
Subject
Witness
I state that I am over eighteen years of age, in good
physical health, and agree to participate in a program of
research being conducted by Professor Freda Smith of
the UIUC Psychology Department entitled, "The Effects
of Sleep Deprivation on Motor Control and Response Time
Tasks." The purpose, procedures, risks, and benefits
of this research have been explained to me and I have
received a written summary of this explanation.
I understand that I may ask questions and I am free to
withdraw at any time.
In the event of physical injury resulting from
participation in this study, I understand that immediate
medical treatment is available at the McKinley Health
Service. I also understand that the University of
Illinois will not provide compensation for any injury
sustained as the result of participation in this research
except as required by law.
Signature of Staff Member
Signature of Subject or
Subject's Representative
Signature of Witness to
Signature
* The elements required for informed consent are listed to the left of the Consent Form itself to indi-
cate the location of each element in this particular example. For research governed by the regula-
tions of the U.S. Department of Health and Human Services or the Food and Drug Administration
additional elements may be required; see Part II, Tables 1 and 2, pages 16-20.
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CONSENT FORM
EXAMPLE II
FOR A PROJECT AT MINIMAL RISK
Required Elements*
Identification of Project
Purpose
Procedures
Risks and/or
Discomforts
Benefits
Freedom to Withdraw
and Opportunity to
Ask Questions
Consent
Name, Address, and
Phone Number of
Investigator
Signature of Subject
Date
CONSENT FOR BLOOD TO BE DRAWN FOR USE IN A RESEARCH PROJECT
I, state that I am over
eighteen (18) years of age and agree to participate in a
program of research being conducted by Professor Stephen
Daedalus of the UIUC Entomology Department.
Purpose of the Project :
To study the effect of fresh and dried human blood on the
digestive system of scarabaeidae and microcentrum.
The experimental procedure for the human subject is to
donate a total of 3 samples of 10 ml. of blood two weeks apart.
The blood will be drawn by a certified medical technologist,
nurse, or other suitably qualified person.
The personal discomforts involved are: slight pain during
the drawing of blood and, in rare cases, development of what
is commonly known as "black and blue mark" caused by minor
seeping of blood around the puncture.
I acknowledge that I have been told that this procedure is not
intended to benefit my personal health -but will provide
material for certain studies of insects.
I acknowledge that Professor Daedatus has fully explained
to me the discomforts involved and the need for the research,
has informed me that I may withdraw from participation
at any time, and has offered to answer any questions which
I may ask about the procedures to be followed. I freely and
voluntarily consent to take part in this research project.
Stephen Daedalus, Responsible Project Investigator
Entomology Department, UIUC
20 Morrill Hall
Phone: 333-6714
Signature of subject
Date
* The elements required for informed consent are listed to the left of the Consent Form itself to indi-
cate the location of each element in this particular example. For research governed by the regula-
tions of the U.S. Department of Health and Human Services or the Food and Drug Administration
additional elements may be required; see Part II, Tables 1 and 2, pages 16-20.
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CONSENT FORM
EXAMPLE III
FOR RESEARCH AT MINIMAL RISK
INVOLVING CHILDREN AS SUBJECTS
Required Elements*
Address of
Investigator
Identification of Project
Procedures
Freedom to Withdraw
at Any Time
Opportunity for Parent
to Ask Questions
Benefits
Purpose
Name and Telephone
Numbers of
Investigators
Consent
Name of Child
Parent Signature
Date
Col lege of Education
Department of Elementary Education
1310 South Sixth Street
Champaign, IL 61820
(2171 333-2245
September 2, 1983
He would like to include your child, along with his or her classmates in a
project to see if we can train 10 and 11 year old children in survey and map-
making skills.
If your child takes part in this project, he or she will get extra training in
the math lab in the school. Your child will also visit the County Court House
to look at land plats and surveys and work with maps in the library. The total
time needed for all training should not be more than eight hours and will take
place over several weeks in April and May. Each child will be asked to give
positive agreement to be included in the study; only those students who want
to take part will do so. Any student may stop taking part at any time. The
information collected from your child during this study will be kept strictly
confidential and will not become a part of his or her school record.
Please let us know on the bottom of this letter whether you do or do not want
your child to participate in this project. Ask your child to bring the reply
to his or her teacher or school principal. If you have any questions about
this research, please do not hesiate to ask them either by mail or by
telephone at the numbers listed below.
We look forward to working with your child. We think that our research may
help improve the map skills of grade school children. We also think that our
research will show that some parts of trigonometry can be studied in earlier
grades in math than teachers have thought.
Yours truly.
L. Ericksen, Associate Professor
(217) 333-2250
1 do/ do not / want my child,
in the study described above.
A. Vespucci, Assistant Professor
(217) 333-8187
, to participate
Name of Child
* The elements required for informed consent are listed to the left of the Consent Form itself to indi-
cate the location of each element in this particular example. For research governed by the regula-
tions of the U.S. Department of Health and Human Services or the Food and Drug Administration
additional elements may be required; see Part II, Tables 1 and 2, pages 16-20.
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Appendix III: Form IRB-1
FORM IRB-1
(9/831
Case No
Reviewers.
UIUC IRB
INFORMATION FOR REVIEW OF RESEARCH INVOLVING HUMAN SUBJECTS
NOTE: All investigators using human subjects should be thoroughly familiar with the policies, definitions, instructions, and pro-
cedures described in the UIUC policy manual, HANDBOOK FOR INVEST/GATORS. FOR THE PROTECT/ON OF HUMAN SUBJECTS
IN RESEARCH (September 1983). This booklet is available from the Executive Secretory, Institutional Review Board, Graduate
College, 125 Coble Hall, phone 333-2670. Inquiries may be directed to the staff at this office.
For projects requiring IRB review, submit this form plus one copy of the proposal for the project to be undertaken to the Insti-
tutional Review Board, 125 CoWe Hall. Please fill in the form os completely as possible; do not refer merely to pages in the
proposal. Attach additional material to the IRB-1 form only after the space available for response to a given question has been
used.
1
. RESPONSIBLE PROJECT INVESTIGATOR:
(qualified faculty or staff supervisor)
Soc. Sec. No.:
NAME OF INVESTIGATOR:
(if different)
Soc. Sec. No.:
DEPARTMENT:
2. TITLE OF PROJECT: PROJECT DATES:
Project .Continuation .Change in procedure for a previously approved project
4. FUNDING: B. Funding Agency C. Grant or Contract No.
A. Status
Proposal in preparation
Pending agency decision D. Name and address of additional agency official to be notified of IRB approval, if
Funded
any:
Not externally funded
E. If this particular project is to be undertaken as part of a training or institutional support program, provide the following
information:
Title of program l
5. TYPE OF INVESTIGATOR: 6. TYPE OF PROJECT: 7. NUMBER OF SUBJECTS:
Faculty Graduate student Research _ Independent study Including individuals
who serve at "controls"
Staff Undergrad. student Demonstration _
Class project
Other
8. TYPE OF SUBJECT: (Check all appropriate blanks in both A. and B.)
B. .Normal volunteer
-In-patient
.Out-patient
-Mentally retarded
Mentally disabled
.Individual with limited dvil
freedom
.Pregnant women, fetuses
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9. Subjects will receive payment or some compensation for participation. (See HANDBOOK pages 8 and 44.)
** ** If yes, state amount and form of payment.
10. Access to subjects will be gained through cooperating institutions. (See HANDBOOK page 8.) If yes, pro-
™ "* vide information specified in HANDBOOK pages 44 and 45 as attachment to this form.
)1. This project involves investigators at another U of I campus or another institution. If yes, identify investi-
*" *° gators and institutions.
12. Project involves use of drugs or medical devices not certified by FDA for clinical use for this purpose. (See
w " HANDBOOK pages 24 and 45.)
13. Investigator has, or has applied for, Investigational New Drug certification by the FDA for the use of drugs
"** "* included in this project. If yes, provide copy of FDA Form *1571.
14. Investigator has or has applied for an Investigational Device Exemption (IDE) from FDA for the use of a
*** "°
significant risk medical device in this project.
15. OBJECTIVES AND SIGNIFICANCE OF THE PROPOSED RESEARCH INVOLVING HUMAN SUBJECTS:
16. VOLUNTARY PARTICIPATION: Describe method (a) for selecting subjects and (b) for assuring that their participation is
voluntary. If subjects are children and they are capable of assent, describe provisions for soliciting their assent as well as
the provisions for soliciting permission of their parent(s) or authorized representative. (For requirements of consent and
assent, see HANDBOOK, page 5 and pages following and 12 and pages following.)
A copy of the consent form to be signed by the subject (if applicable) and/or any explanation to be given to the subject
should be attached to this form. If no consent form is to be used, explain the procedures to be used to assure that participa-
tion is voluntary. If any information is withheld from subjects, identify, justify the withholding, and describe debriefing plan
if any. Special requirements for consent need to be met for certain subject populations See especially Table 1, page 16
and pages following.
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17 PROCEDURES: Describe how subjects will be involved. (Attach additional page only if more space is needed.)
18. CONFIDENTIALITY OF DATA: If data are collected which could be associated with individual subjects, describe the methods
to be used to ensure the confidentiality of data obtained. (See HANDBOOK pages 7, 21, and 42.) Confidentiality for data
will be required unless subjects give express permission that their data may be identified.
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19 RISKS: Will subjects in the proposed worlc be placed at more than minimal risk las defined in HANDBOOK pages 21-24)?
Minimal risk More than minimal risk Uncertain
Describe the risks to the subject (whether or not you consider them to be risks of ordinary life) and precautions that will be
taken to minimize them. The concept of risk goes beyond physical risk and includes risks to hV> subject's dignity and self-
respect, as well as psychological, emotional, or behavioral risk.
20. BENEFITS: Describe the benefits to the subject and/or society. The IRB must have sufficient information to make a determina-
tion that the benefits outweigh whatever risks ore involved. (See HANDBOOK pages 2, 3, 12, 16, 41, and 42.)
CERTIFICATIONS:
1. I am familiar with the HANDBOOK FOR INVESTIGATORS (September 1983). I will adhere to the policies and procedures
explained therein.
2. Should changes in procedures involving human subjects become advisable, I will submit them for review prior to initiating the
change.
3. If any problems involving human subjects occur, I will immediately notify the Departmental Executive Officer and the Execu-
tive Secretary of the Institutional Review Board.
Signatures: Date:
IViponiibk Project Inveitigolor («PI) Inveiligotor, if different from tPI
FOR OPTIONAL DEPARTMENTAL USE:
The activity described herein is in conformity with IRB-approved departmental guidelines.
Departmental Executive Officer
(or deilqnee)
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Appendix IV: Requirements for Federally
Funded 1 Research Involving
Certain Subject Populations
A. SPECIAL REQUIREMENTS FOR FEDERALLY FUNDED
RESEARCH INVOLVING CHILDREN
In addition to the requirements specified elsewhere in this handbook, the fol-
lowing requirements are imposed on all research involving children that is
supported by or governed by HHS regulations.2
1. Consent
a. Assent of Children
i. The IRB shall determine that adequate provisions are made for solicit-
ing the assent of children who are subjects in research, when, in the
judgment of the IRB, the children are capable of providing assent.
In determining whether children are capable of assenting, the IRB
shall take into account the ages, maturity, and psychological state of the
children involved. This judgment may be made for all children to be
involved in research under a particular protocol or for each child, as the
IRB deems appropriate.
If the IRB determines that the capability of some or all of the chil-
dren is so limited that they cannot reasonably be consulted or that the
intervention or procedure involved in the research holds out a prospect
of direct benefit that is important to the health or well-being of the
children and is available only in the context of the research, the assent
of the children is not a necessary condition for proceeding with the re-
search.
Even where the IRB determines that the subjects are capable of
assenting, the IRB may still waive the assent requirements under cer-
tain circumstances. (See Table 1, especially parts A.(c), (d), and (f),
B.(a.3) and (b).)
ii. For research involving children capable of assent, the IRB will re-
quire the investigator to propose what the child will be told about the
research, how the information will be presented to him or her, and
how assent will be obtained. The information presented to the child
will vary from a simple description of what the child will experience
to the equivalent of the information that would be presented to an adult
subject. Younger and less sophisticated children will be given simple
information on what they will experience as they participate in the
1 Most federal sponsors of research require compliance with HHS regulations for
the protection of human subjects in research.
3 HHS Regulations on "Children Involved as Subjects in Research: Additional Pro-
tections" was published in the Federal Register, vol. 48, no. 46, March 8, 1983,
pages 9814-9819.
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research. For older and more sophisticated children, more detailed
information will be given together with a statement about the fact
that the project is for the purpose of research. All children must be in-
formed that they are free to withdraw from participation at any time.
The IRB will review and approve methods for assuring assent and
base its decisions on the premise that, like maturity, a child's under-
standing is a gradually expanding developmental process which cannot
be stated in terms of chronological age, as well as on the principle
that the autonomy of all persons should be respected.
Permission of Parents or Guardian
i. When children are subjects in research, the IRB shall determine, in
accordance with and to the extent that consent is required by UIUC
policy stated in Part II, Section D.l. (pages 12-20), that adequate
provisions are made for soliciting the permission of each child's par-
ents or guardian. Where parental permission is to be obtained, the
IRB may find that the permission of one parent is sufficient for re-
search to be conducted where:
• the research does not involve greater than minimal risk,
• the research involves greater than minimal risk, but presents the
prospect of direct benefit to the individual subjects.
it. When children are included in:
• research involving greater than minimal risk and no prospect of di-
rect benefit to individual subjects, but likely to yield generalizable
knowledge about the subjects' disorder or condition or
• research not otherwise approvable that presents an opportunity to
understand, prevent, or alleviate a serious problem affecting the
health of children and permission is to be obtained from parents
then both parents must give their permission unless one parent is
deceased, unknown, incompetent, or not reasonably available, or
when only one parent has legal responsibility for the care and cus-
tody of the child.
Consent May Be Waived
Under several circumstances, the IRB may waive some or all of the
consent requirements. The waiver conditions for all types of research
projects are described in Table 1, Part A.(c), (d), and (f) and Part B.(a)
and (b). In addition, the IRB may waive consent of the parents or
guardian if the IRB determines that:
£. a research protocol is designed for conditions or for a subject popula-
tion for which parental or guardian permission is not a reasonable
requirement to protect the subjects (for example, neglected or abused
children), and
ii. the waiver is not inconsistent- with federal, state, or local laws, and
Hi. an appropriate mechanism for protecting the children who will par-
ticipate as subjects in the research is substituted. The choice of an
appropriate mechanism would depend upon the nature and purpose
of the activities described in the protocol; the risk and anticipated
benefit to the research subjects; and their age, status, and condition.
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d. Documentation of Informed Consent and Assent
When children are included as subjects in research, permission by parents
or guardians shall be documented in accordance with and to the extent
required by a. through c. above. When the IRB determines that assent is
required, it shall also determine whether and how assent must be docu-
mented.
2. Criteria for Approval by the IRB
a. Research involving not greater than minimal risk
When children are included in research involving not greater than minimal
risk, the IRB must find that adequate provisions are made for soliciting
the assent of children and the permission of their parents.
b. Research involving more than minimal risk, but presenting the prospect
of direct benefit to individual subjects
When children are included in research in which the IRB finds that more
than minimal risk is presented by an intervention or procedure that holds
out the prospect of direct benefit to the individual subject or by a moni-
toring procedure that is likely to contribute to the subject's well-being, the
IRB must find that:
i. the risk is justified by the anticipated benefit to the subjects, and
ii. the relation of the anticipated benefit to the risk is at least as favorable
to the subjects as that presented by available alternative approaches,
and
Hi. adequate provisions are made for soliciting the assent of children and
permission of their parents and guardians.
c. Research involving greater than minimal risk and no prospect of direct
benefit to individual subjects, but likely to yield generalizable knowledge
about the subjects' disorder or condition
Where children are included in research in which more than minimal
risk to children is presented by an intervention or procedure that does not
hold out the prospect of direct benefit for the individual subject, or by a
monitoring procedure which is not likely to contribute to the well-
being of the subjects, the IRB must find that:
x. the risk represents a minor increase over minimal risk, and
ii. the intervention or procedure presents experiences to subjects that are
reasonably commensurate with those inherent in their actual or ex-
pected medical, dental, psychological, social, or educational situations,
and
Hi. the intervention or procedure is likely to yield generalizable knowledge
about the subjects' disorder or condition which is of vital importance
for the understanding or amelioration of the subjects' disorder or con-
dition, and
iv. adequate provisions are made for soliciting assent of the children and
permission of their parents or guardians.
d. Research not otherwise approvable
Where children are included in plans for research not otherwise approvable,
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i. the IRB must find that the research presents a reasonable opportunity
to further the understanding, prevention, or alleviation of a serious
problem affecting the health or welfare of children, and
ii. the Secretary of Health and Human Services, after consultation with a
panel of experts in pertinent disciplines (e.g., science, medicine, edu-
cation, ethics, law) and following an opportunity for public review and
comment, has determined that the research is, in fact, approvable by
the IRB or that
:
'• the research presents a reasonable opportunity to further the under-
standing, prevention, or alleviation of a serious problem affecting the
health or welfare of children; and
• the research will be conducted in accordance with sound ethical
principles; and
• adequate provisions are made for soliciting the assent of children and
the permission of their parents or guardians.
e. When children who are wards of the state are involved as subjects in
research
i. The requirements for children who are wards of the state or any other
agency, institution, or entity do not differ from those for other children
if the research
:
a. involves no more than minimal risk or
b. involves greater than minimal risk, but presents the prospect of di-
rect benefit to the individual subjects.
ii. Children who are wards of the state or any other agency, institution,
or entity can be included in research described in Section 2., c. or d.
above only if the research is:
a. related to their status as wards; or
b. conducted in schools, camps, hospitals, institutions, or similar settings
in which the majority of children involved as subjects are not wards.
Hi. If the research is approved under Section 1.e.ii. (immediately above),
the IRB will require appointment of an advocate for each child who
is a ward in addition to any other individual acting on behalf of the
child as guardian or in loco parentis.
3. Exemptions
When children are involved as subjects in research regulated by HHS, the
kinds of research that are exempted from prior review are more limited
than when children are not involved. Note the following:
Exemption 3: The exemption from prior review of research involving sur-
vey or interview procedures does not apply to research involving children.
Such projects must be submitted to the IRB for review. (See page 29.)
Exemption 4: The exemption from prior review of research involving ob-
servation of public behavior applies to research involving children only if
the investigator (s) does not participate in the activity being observed. (See
page 30.)
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B. SPECIAL REQUIREMENTS FOR FEDERALLY FUNDED
RESEARCH INVOLVING PRISONERS AS SUBJECTS
In addition to the requirements specified elsewhere in this handbook, the fol-
lowing requirements are imposed on all research involving prisoners that is
supported by or governed by HHS regulations.
1. General Limitations
The only types of research involving prisoners which may be approved by the
IRB are the following:
a. Study of the possible causes, effects, and processes of incarceration, and of
criminal behavior, provided that the study presents no more than minimal
risk and no more than inconvenience to the subjects;
b. Study of prisons as institutional structures or of prisoners as incarcerated
persons, provided that the study presents no more than minimal risk and
no more than inconvenience to the subjects;
c. Research on conditions particularly affecting prisoners as a class (for ex-
ample, vaccine trials and other research on hepatitis which is much more
prevalent in prisons than elsewhere; and research on social and psycho-
logical problems such as alcoholism, drug addiction, and sexual assaults)
provided that the study may proceed only after the Secretary of Health
and Human Services has consulted with appropriate experts, including
experts in penology, medicine, and ethics and published notice in the
Federal Register of his or her intent to approve such research; or
d. Research on practices, both innovative and accepted, which have the in-
tent and reasonable probability of improving the health or well-being
of the subject. In cases in which those studies require the assignment of
prisoners in a manner consistent with protocols approved by the IRB to
control groups that may not benefit from the research, the study may
proceed only after the Secretary of Health and Human Services has
consulted with appropriate experts, including experts in penology, medi-
cine, and ethics and published notice in the Federal Register of his or
her intent to approve such research.
2. Criteria for Approval by the IRB
In addition to applying other criteria for approval (Tables 6A and 6B), the
IRB shall make the following determinations:
a. Any possible advantages accruing to the prisoner through his or her par-
ticipation in the research, when compared to the general living conditions,
medical care, quality of food, amenities, and opportunity for earnings in
the prison, are not of such a magnitude that his or her ability to weigh
the risks of the research against the value of such advantages in the
limited choice environment of the prison is impaired.
b. The risks involved in the research are commensurate with risks that would
be accepted by nonprisoner volunteers.
c. Procedures for the selection of subjects within the prison are fair to all
prisoners and immune from arbitrary intervention by prison authorities or
prisoners. Unless the principal investigator provides to the IRB justifica-
tion in writing for following some other procedures, control subjects must
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be selected randomly from the group of available prisoners who meet the
characteristics needed for that particular research project.
d. The information is presented in language that is understandable to the
subject population.
e. Adequate assurance exists that parole boards will not take into account
a prisoner's participation in the research in making decisions regarding
parole, and each prisoner is clearly informed in advance that participa-
tion in the research will have no effect on his or her parole; and
f. Where the IRB finds there may be a need for follow-up examination or
care of participants after the end of their participation, adequate pro-
vision has been made for such examination or care, taking into account
the varying lengths of individual prisoners' sentences and for informing
participants of this fact.
3. Exemptions
All research governed by HHS regulations involving prisoners must be re-
viewed by the IRB. No research governed by HHS regulations that involves
prisoners as subjects is exempt from prior review by the IRB.
C. SPECIAL REQUIREMENTS FOR FEDERALLY FUNDED
RESEARCH INVOLVING FETUSES, PREGNANT WOMEN,
AND HUMAN IN VITRO FERTILIZATION*
In addition to the requirements specified elsewhere in this handbook, the fol-
lowing requirements are imposed on all research involving fetuses, pregnant
women, and human in vitro fertilization.
1. General Limitations
The only conditions under which research involving fetuses, pregnant
women, and human in vitro fertilization are permitted are the following:
a. appropriate studies on animals and nonpregnant individuals have been
completed;
b. except where the purpose of the research is to meet the health needs of
the mother of the particular fetus, the risk to the fetus is minimal and,
in all cases, is the least possible risk for achieving the objectives of the
research;
c. individuals engaged in the research will have no part in: (i) any deci-
sions as to the timing, method, and procedures used to terminate the
pregnancy and (ii) determining the viability of the fetus at the termina-
tion of the pregnancy;
d. no procedural changes that may cause greater than minimal risk to the
fetus or the pregnant woman will be introduced into the procedure for
terminating the pregnancy solely in the interest of the research; and
* The full text of the HHS regulations concerning research involving pregnant
women, fetuses, and human in vitro fertilization can be found in the Federal Regis-
ter as follows: 40 FR 33528, August 8, 1975 as amended at 40 FR 51638, Novem-
ber 6, 1975; 43 FR 1758, January 11, 1978; 43 FR 51559, November 3, 1978.
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e. no inducements, monetary or otherwise, may be offered to terminate
the pregnancy for purposes of the research.
2. Additional Criteria for IRB Approval
In addition to applying the other criteria for approval (Tables 6A and 6B,
pages 41 and 42), the IRB will determine the following:
a. For research directed toward pregnant women as subjects
t. No pregnant woman may be involved as a subject in research unless:
• the purpose of the research is to meet the health needs of the
mother, and the fetus will be placed at risk only to the minimum
extent necessary to meet such needs, or
• the risk to the fetus is minimal.
«. Research permitted under paragraph a. of this section may be con-
ducted only if the mother and father are legally competent and have
given their informed consent after having been fully informed regard-
ing the possible impact on the fetus, except that the father's informed
consent need not be secured if:
• the purpose of the research is to meet the health needs of the
mother, or
• his identity or whereabouts cannot reasonably be ascertained, or
• he is not reasonably available, or
• the pregnancy resulted from rape.
b. For research directed toward fetuses in utero as subjects
:. No fetus in utero may be involved as a subject in any research unless:
• the purpose of the research is to meet the health needs of the
particular fetus and the fetus will be placed at risk only to the
minimum extent necessary to meet such needs, or
• the risk to the fetus imposed by the research is minimal and the
purpose of the research is the development of important biomedical
knowledge which cannot be obtained by other means.
it. Such research may be conducted only if the mother and father are
legally competent and have given their informed consent, except that
the father's consent need not be secured if:
• his identity or whereabouts cannot reasonably be ascertained, or
• he is not reasonably available, or
• the pregnancy resulted from rape.
c. Research directed toward fetuses ex utero, including nonviable fetuses, as
subjects
i. Until it has been ascertained whether or not a fetus ex utero is viable,
a fetus ex utero may not be involved as a subject in research unless:
• there will be no added risk to the fetus resulting from the research
and the purpose of the activity is the development of important
biomedical knowledge that cannot be obtained by other means, or
• the purpose of the research is to enhance the possibility of survival
of the particular fetus to the point of viability.
»i. No nonviable fetus may be involved as a subject in research unless:
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• vital functions of the fetus will not be artificially maintained,
• experimental research, which of itself would terminate the heart-
beat or respiration of the fetus, will not be employed, and
• the purpose of the research is the development of important bio-
medical knowledge that cannot be obtained by other means.
Hi. In the event the fetus ex utero is found to be viable, it may be in-
cluded as a subject in the research only to the extent permitted by
the other requirements listed above.
iv. Such research may be conducted only if the mother and father are
legally competent and have given their informed consent, except that
the father's informed consent need not be secured if:
'• his identity or whereabouts cannot reasonably be ascertained, or
• he is not reasonably available, or
• the pregnancy resulted from rape.
d. For research involving the dead fetus, fetal material, or the placenta
Activities involving the dead fetus; mascerated fetal material; or cells,
tissue, or organs excised from a dead fetus shall be conducted only in
accordance with any applicable state or local laws regarding such research.
3. Modification or Waiver of Specific Requirements
Upon the request of an applicant (with the approval of the Institutional
Review Board), the Secretary of Health and Human Services may modify or
waive specific requirements listed above with the approval of the Ethical
Advisory Board after such opportunity for public comment as the Ethical
Advisory Board considers appropriate in the particular instance. In mak-
ing such decisions, the Secretary will consider whether the risks to the sub-
ject are so outweighed by the sum of the benefit to the subject and the
importance of the knowledge to be gained as to warrant such modification
or waiver and that such benefits cannot be gained except through a modifica-
tion or waiver. Any such modifications or waivers will be published as notices
in the Federal Register.
4. Exemptions
No research governed by HHS regulations directed toward pregnant women
or fetuses is exempt from prior review by the IRB.
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